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Report of the Federal Panel
on Formaldehyde*
The Federal Panel on Formaldehyde concluded thatdefinitive experiments existwhichdemonstrate
the mutagenicity and carcinogenicity of formaldehyde under laboratory conditions. Formalde-
hyde induces both gene mutations and chromosomal aberrations in a variety of test systems.
Inhalation of formaldehyde causes cancer of the nose in rats. The concentrations of formalde-
hyde in inhaled air that caused nasal cancer in Fisher 344 rats are within the same order of
magnitude as those to which humans may be exposed. The data presently available do not permit
a direct assessment of the carcinogenicity of formaldehyde to man. Epidemiologic studies on
exposed human populations are in progress and may further clarify the situation. Other
experimental and human studies on toxic effects such as teratogenicity and reproductive
disorders are as yet inadequate for a health risk assessment.
The CIIT 24 month study on animal carcinogenicity has not yet been completely evaluated.
Additional data are expected on the effects ofprolonged exposure to lowerdoses offormaldehyde
and on the possible carcinogenicity offormaldehyde in the mouse. The panel recommends that,
for a comprehensive health risk assessment, further experiments be conducted on the effects of
other modes of exposure (ingestion and skin penetration), the effects in humans, and on the
pharmacokinetics offormaldehyde in man and animals and the possible role forformaldehyde in
reproductive and chronic respiratory disorders.
It is the conclusion ofthe panel that formaldehyde should be presumed to pose a carcinogenic
risk to humans.
Introduction
The first evidence that formaldehyde might rep-
resent a carcinogenic risk for man was obtained in
October 1979 from an ongoing animal experiment
conducted by Battelle Columbus Laboratories for
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theChemicalIndustryInstituteofToxicology(CIIT)
(1). The preliminary results were reviewed by Fed-
eral Government scientists, who concurred with
the CIITconclusions. Astheexperimentprogressed
and more data became available, the need for a full
review ofthe potential health risks to humans from
chronic exposure to formaldehyde became evident.
To accomplish this review, a panel of scientists
from within the Federal Government was formed in
April, 1980, under the auspices of the National
Toxicology Program and coordinated by the Con-
sumer Product Safety Commission. The panel mem-
bersreviewedandevaluatedtheavailablepublished
and unpublished information on the adverse health
effects from repeated exposure to formaldehyde.
Acute toxic effects and hypersensitivity were not
considered, since they had recently been assessed
by the Committee on Toxicology of the National
Academy of Sciences (2).
Nearly seven billion pounds offormaldehyde are
produced each year in the United States (3), most
in the manufacture of urea-, phenol-, acetal-, and
melamine-formaldehyde resins. The remainder is
139used to make other industrial chemicals, agricul-
ture products, leather products, to preserve cos-
metics, and to prepare vaccines, drugs, fumigants,
and disinfectants. The formaldehyde-based resins
are used as adhesives in the manufacture ofparticle
board, veneers, and plywood, and in the production
of insulating materials, plastics, protective coat-
ings, textiles, paper, and rubber products.
Under certain conditions, formaldehyde may be
released from some ofthese products, creating the
potential for human exposure to the chemical. Its
presence in building materials, such as insulation,
particle board, and plywood, as well as in other
products, has resulted in complaints to the federal
regulatory agencies. For example, the Consumer
Product Safety Commission (CPSC) has received a
number of complaints from consumers concerning
adverse health effects associated with the release of
formaldehyde gasfromurea-formaldehydefoaminsu-
lation (4). Consumers have also expressed concern
that the high concentrations offormaldehyde within
their mobile homes may be unhealthy (5). Com-
plaints such as these arise because formaldehyde
causes irritation ofthe eyes, nose, throat, and skin,
persistent cough, shortness ofbreath, nausea, head-
aches, and dizziness. Similar symptoms have been
reported by workers who were exposed to formal-
dehyde resins that are used in the wood, textile,
rubber and leather industries.
In October 1979, federal regulatory and research
agencies became greatly concerned about the expo-
sure of humans to formaldehyde when representa-
tives of the Formaldehyde Institute reported pre-
liminaryfindingsfromacarcinogenicitystudyshowing
that rats exposed to 15 ppm offormaldehyde devel-
oped squamous cell carcinoma ofthe nose (1). This
concern was reinforced in January, 1980, when
representatives ofthe InteragencyRegulatory Liai-
son Group (IRLG) reviewed the carcinogenicity
data in detail (6). As a result, CPSC, in cooperation
with the IRLG agencies, convened a panel ofscien-
tists from eight federal agencies under the auspices
ofthe NationalToxicologyProgramtoreviewhealth
datarelated toformaldehyde. Aspart ofthisreview,
the panel members were asked to consider the
following questions (7):
* Is there evidence indicating that formaldehyde
maybetumorigenic/carcinogenic atdoses other
than 15 ppm in the CIIT study?
* Are there confounding factors in the CIIT
study such as the irritating properties of
formaldehyde, viral infection, special sus-
ceptibility of the rat to irritants, or proto-
col defects? If so, what are the relative
merits of these factors?
* What conclusions can be drawn from the
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tumorigenic/carcinogenic results in the CIIT
study?
* What is the applicability of the conclusions
drawn in the CIIT study to the human situa-
tion?
* What is the relation of animal data from other
irritant carcinogens to the human situation?
* How do other formaldehyde studies in animals
and epidemiological studies affect conclusions
about the human carcinogenicity of formalde-
hyde?
* Do short-term mutagenicity data support
findings of carcinogenicity?
* What conclusions can be reached concerning
the potential human carcinogenicity of formal-
dehyde?
* Are there additional data needed?
* Are these findings relevant to exposure from
other routes?
* Is there evidence that formaldehyde is
teratogenic or causes reproductive effects?
To address these questions the panel evaluated
the published literature and available data from
ongoing studies. This report is the result of the
panel's review.
Chemistry and Metabolism
Chemistry
Formaldehyde,-a one-carbon compound with the
formula HCHO, has a molecular weight of30.3 and
a boiling point of19°C. In the gaseous state formal-
dehyde is a highly reactive chemical with a charac-
teristic pungent odor. It is readily soluble in nonpo-
lar solvents such as chloroform, ether, or toluene
but undergoes solvation in polar solvents such as
water or methanol. Synthesis of formaldehyde is
accomplished typically by the oxidation ofmethanol
in the presence of a copper or silver catalyst.
The common commercial form of formaldehyde
(formalin) contains 37-50% formaldehyde in water
by weight and is stabilized against polymerization
by the addition of 1-15% methanol. Formaldehyde
is also commercially available as a solid linear
polymercontaining91-95% formaldehyde and 5-9%
water (paraformaldehyde or polyoxymethylene) or
as a cyclic polymer (trioxane or trioxymethylene).
Trioxane, unlike polyoxymethylene, does not read-
ilyundergo depolymerizationundermostconditions.
Formaldehyde undergoes the following chemical
reactions in biological systems (8):
Hydration in the presence of water:
HCHO+ H20 ->CH2(OH)2 (1)
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amines, or amides:
RNH2 + HCHO -* RNHCH20H (2a)
RNHCH20H + RNH2 > RNHCH2NHR + H20 (2b)
RCONH2 + HCHO ->RCONHCH20H (3a)
RCONHCH20H + RCONH2 >
RCONHCH2NHOCR + H20 (3b)
These reactions are ofparticular concern because
ofthe ubiquity ofnitrogen compounds (DNA, RNA,
proteins, amino acids, etc.) in all biological systems.
The reaction with purines and other amines pro-
duces an intermediate methylol product which is
labile. The reaction product with a second amine
moiety is stable.
Reaction with other compounds having active
hydrogens such as thiols, nitroalkanes, hydrogen
cyanide, and phenol:
HCHO + HSCH2CHCOOH > H2CSCHQHCOOH (4)
NH2 OH NH2
Condensation with HCI (and possibly other inor-
ganic chlorides) in the presence of water to form
bis(chloromethyl) ether:
2HCHO + 2HC1 > CICH20CH2C1 + H20 (5)
Metabolism
Formaldehyde can enter the body through inha-
lation, ingestion or dermal absorption. Absorption
offormaldehydethroughtheupperrespiratorytract
in dogs has been estimated to exceed 95% of the
inhaled dose (9). Following oral exposure ofdogs to
formaldehyde, formate levels in blood increased
rapidlyindicatingrapiduptake andmetabolism(10).
Dermal absorption has also been demonstrated (11)
but does not appear to be significant in comparison
to inhalation or ingestion.
Formaldehyde that enters the body appears to be
converted rapidly to formate (10, 12) or to combine
with tissue constituents by the reactions described
above. The conversion offormaldehyde to formate
occurs following intravenous (IV) infusion, subcu-
taneous injection, gastric intubation, or inhalation.
Studies using IV infusion of 0.2M formaldehyde
into dogs have shown that only a small amount of
formaldehyde appears in the plasma during expo-
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sure (10). This becomes undetectable within 1 hr
after cessation of infusion. The peak formate con-
centration following formaldehyde infusion was the
same as when formate (0.2M) itself was infused.
The plasma halflife for formate (between 80 and 90
min) was also similar. Formaldehyde could not be
detected after oral administration of 0.2M formal-
dehyde in the same study while formate increased
rapidly in the plasma with a halflife of 81.5 min.
Similar experiments on cynomolgus monkeys, in
which 0.2M formaldehyde was infused IV, likewise
showed no accumulation of formaldehyde in blood
(12). The blood halflife was estimated to be 1.5 min.
Similar halflives for blood formaldehyde have been
observed in rats, guinea pigs, rabbits and cats (13).
In a somewhat different experiment, McMartin et
al. (14) administered '4C-methanol by gastric intu-
bation. Again, formaldehyde could not be detected
although formate levels increased rapidly. A study
inwhich humans were exposed toformaldehyde gas
(0.78mg/m3) for 3 hr also demonstrated a rapid rise
in blood and urine formate levels (15).
The rapid conversion offormaldehyde to formate
occurred in many tissues in the various species
examined, including human erythrocytes (10), liver
and brain; sheep liver; rat brain, kidney and mus-
cle; rabbit brain; and bovine brain and adrenals
(16). The enzymes involved have been studied by
Strittmatter and Ball (17) as well as by Uotila and
Koivusalo (16). The oxidation is initiated by forma-
tion ofS-formyl glutathione which is then oxidized
by NAD and finally cleaved by a thiol esterase,
releasing formic acid and glutathione. Formalde-
hyde has alsobeenreported to be oxidized to formic
acid by a nonspecific aldehyde dehydrogenase and
by the tetrahydrofolic acid pathway (18).
Additional studies (19) have shown that following
subcutaneous administration of '4C-formaldehyde
to rats, approximately 81% of the radioactivity
appeared as CO2. A small amount ofthe radioactiv-
ity was found in choline. Almost 60% of a subcuta-
neous dose of 14C-formate similarly appeared as
14C-CO2, with small amounts of radioactivity in
choline. Neely (20) administered formaldehyde intra-
peritoneally (IP) to rats and found that 82% of
radiolabel was recovered as CO2 and 13-14% as
urinary methionine, serine and a cysteine adduct.
At lower doses, only methionine was labeled. The
author postulated that CO2 was derived from serine
(formed from glycine and N5, Nl0-methylene tetra-
hydrofolate) by deamination to pyruvate and oxida-
tion in the Krebs cycle. The formation of methio-
nine from 14C-formaldehyde and homocysteine had
previously been demonstrated by Berg (21). For-
mation of methionine would also account for the
labeled choline observed by DuVigneaud et al. (19)
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FIGURE 1. Simplified reaction sequence from drug N-demethylation (cytochrome-P450-dependent monooxygenase) to formaldehyde,
formate, and CO2 production. Reactions are: la, formaldehyde dehydrogenase (GSH); lb, aldehyde dehydrogenase; lc, catalase
(peroxidatic mode); 2a, l1-formyltetrahydrofolate synthetase; 2b, 10-formyltetrahydrofolate dehydrogenase; 2c, catalase (peroxidatic
mode).
viamethylationofphosphatidylethanolamine. More
recent work by Pruett et al. (22) has demonstrated
the incorporation of "4C-formaldehyde into the nu-
cleic acid and protein fractions of WI 38 human
diploid fibroblasts. Most oftheradiolabel was found
in RNA with lesser amounts in DNA and protein.
Thepurine bases ofboth DNA and RNA were most
heavily labeled.
In addition to the serine pathway to C02 postu-
lated above (20), two other pathways have been
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identified. TheseareshowninFigure 1 fromWaydhas
et al. (23).
Waydhas et al. (23), McMartin et al. (14) and
Palese and Tephly (24) have demonstrated that the
catalase reaction (Fig. 1) is not ofmajorimportance
and that the primary pathway to CO2 from formate
occurs via the tetrahydrofolic acid pathway. This
has been demonstrated in rat liver perfusates (23),
monkeys (14)andrats(24). Sincethetetrahydrofolic
acid pathway (Fig. 2), from Kitchens et al. (2), can
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FIGURE 2. Sources offormate. FH4 = tetrahydrofolic acid; f"MFH4 = N"0 formyltetrahydrofolic acid; f5FH4 = N5 formyltetrahydrofolic
acid; f5-0FH4 = N5 - N'0 methylnyltetrahydrofolic acid; fi5FH4 = N' formininotetrahydrofolic acid; h5--'FH4 = N'0 methylene-
tetrahydrofolic acid.
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)
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number ofother compounds (including serine), it is
not clear that the 10-formyltetrahydrofolate dehy-
drogenase reaction (Fig. 1) is the only reaction of
importance for CO2 production in this pathway.
The sources of formate in Figure 2 include the
degradation of amino acids such as histidine and
tryptophan, and possibly serine and glycine as well.
Formaldehyde or formate can also result from
N-demethylation of drugs such as aminopyrine or
ethylmorphine (23, 25) or the metabolism ofdihalo-
methanes (26).
Formaldehyde can be formed in mammalian tis-
sues (pig brain and rat kidney) by enzymatic hydrol-
ysis of5-methyl tetrahydrofolate, in a reaction that
appears to require the presence ofbiogenic amines.
The reaction between the amine and formaldehyde
is nonenzymatic and leads to the formation of vari-
ous alkaloids (27). A similar reaction involving N5,
N'0-methylene tetrahydrofolate is found in human
lymphocytes, brain, kidney, and platelets (28); it
also apparently requires an amine acceptor. Form-
aldehyde can additionally result from the action of
mixed function oxidases on the N-methyl groups of
various xenobiotics (29). The authors report, how-
ever, that the rate of oxidation of formaldehyde to
formate is higher than the rate of formation of
formaldehyde in the above reaction.
Finally, whereas the conversion offormaldehyde
to CO2 occurs in a similar manner in the different
species studied, the relative importance of each
reaction differs among species and tissues. Thus,
the rat is able to convert formate to CO2 at more
than twice the rate of monkeys (or man) and, as a
result, has lower blood formate levels (14) and does
not excrete formate in the urine (20). Man addition-
ally possesses 50% more hepatic dehydrogenase
than do rats (30). With regard to tissue differences,
Den Engelse et al. (31) have shown that mouse
(C3Hf/A) and hamster (Syrian Golden) lungs do not
convert formate to CO2 as efficiently as liver tissue
does.
In summary, free formaldehyde is not usually
found in plasma or otherbody tissues in measurable
quantities, such endogenous formaldehyde as is
produced maybereasonably presumed tobe metab-
olized rapidly to formate or to enter the one carbon
pool. When exogenous exposure does occur, form-
aldehyde is likewise rapidly metabolized to formate
and excreted, converted to CO2 and/orincorporated
into other molecules. The same paths seem to occur
in all mammalian species examined to date, but
reaction rates differ among various species and
tissues. Neither the ratio ofmetabolic deactivation,
to tissue or small molecule binding, northe effect of
route of exposure on this ratio is known at this
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FIGURE 3. Overall metabolism of formaldehyde.
time. Thus, although Egle's work (9) suggests that
the respiratory tract is the primary area at risk for
tumor development, other body sites cannot be
ruled out.
The overall metabolism of formaldehyde is sum-
marized in Figure 3 (adapted from Kitchens et al.)
(8).
As can be seen from Figure 3, formaldehyde is
more chemicallyactive thananyofitsdirectmetabo-
lites and would therefore appear to be the chemical
substance ofmost concern for carcinogenicity. The
possibilityexists, however, asproposedbyPoverenny
et al. (32), that the actual carcinogenic agent may
be an amino acid (or other) adduct.
Teratology and Reproduction
Reproduction and Teratology Studies
in Animals
The effects of formaldehyde or hexamethylene-
tetramine (HMT) on teratology and reproduction in
laboratory animals have been studied using four
methods ofadministration: inhalation, oral gavage,
dietary, or in drinking water. Because the method
of administration might have affected the results,
the studies are presented chronologically for each
method. Hexamethylenetetramine (HMT), an anti-
microbial food additive, degrades to formaldehyde
and ammonia in an acid medium or in the presence
of protein, as in the digestive tract (33).
Inhalation Studies. Gofmekler and his col-
leagues studied the teratogenic and toxic effects of
fornaldehydein36femalerats(12pergroup)exposed
to 0, 0.012 or 1.0 mg/m3 from 10 to 14 days before
impregnation through gestation. Three male rats
per dose level were also exposed for 6-10 days
before they were mated.
Gofmekler (34) reported the effect of formalde-
hyde on fertility, fetal weights and organ weights.
In both treated groups, formaldehyde caused a
14-15% increase in the length of gestation; it also
143increased the average body weight ofthe offspring
andtheirheart, adrenal, and kidney weights. These
changes might have resulted from the extended
gestation time. In contrast, the liver and lungs
from pups in the treated groups weighed less than
thoseofthecontrolpups. AlthoughGofmeklerstated
that there was a decrease in the litter size, his data
suggest that this may not be accurate. Our calcula-
tions, based on data in Gofmekler's article, show
that groups exposed to 0.012 and 1.0 mg/m3 of
formaldehyde had average litter sizes of 19.6 and
17.3 pups, respectively, as compared to the con-
trol value of 11.2. These calculations assume
that all females in each group became pregnant.
Gofmekler stated that some females in each group
did not become pregnant, but did not report the
details. This implies that several dams produced
over 20 pups each.
Gofmekler, Pushkina and Klevtsova (35) reported
data related to changes in the developing embryo.
IdenticaldatawerereportedbyPushkina, Gofmekler,
and Klevtsova (36). They measured ascorbic acid in
whole embryo, placenta, maternal liver and fetal
liver; "nucleic acids" (apparently RNA) in maternal
liver, fetal brain and fetal liver; and DNA in mater-
nal and fetal liver. Significant decreases in ascorbic
acid concentrations occurred in the whole embryo
and in the maternal liver at both dose levels. A
significant increase in ascorbic acid concentration in
liver occurred in offspring from dams exposed to
0.012 mg/m3. RNA concentrations in maternal liv-
ers were greater at both dose levels than they were
in controls. RNA concentrations offetal brain were
similar in control and treated groups. DNA content
was significantly lower in maternal and fetalliverin
both treated groups than in control animals. The
authors concluded that formaldehyde "significantly
inhibited the synthesis of nucleic acids." This con-
clusion is not, however, supported by the data in
the article.
Gofmekler and Bonashevskaya (37) reported the
data related to histopathological changes in the
liver and kidneys of fetuses from dams exposed to
formaldehyde. The hepatic changes included an
increased proliferation of epithelial cells in the bile
duct and segmented forms in the hepatic sinusoids.
The kidney changes included renal epithelial cells
with polymorphic nuclei, casts in the lumina of
some tubules, and functional alterations inthe renal
tubule apparatus. Exposure to 1.0mg/m3 offormal-
dehyde also caused a decrease in myocardial glyco-
gen, an involution of the thymic lymphoid tissue
and disintegration of lymphocytes. Histologically,
the testes of adult males exposed to formaldehyde
were similar to those of the controls.
From macroscopic evaluation it was reported
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that formaldehyde inhalation by pregnant dams did
not affect embryonic or fetal development.
Sheveleva (38) studied the teratogenic potential
of formaldehyde in pregnant albino rats. The rats
were exposed to 0.005, 0.0005 or 0 mg/l of formal-
dehyde for 4 hr each day on days 1-19 ofgestation.
Fifteen females per group were killed on day 20,
while six were kept to obtain progeny. On day 17 of
pregnancy, bodyweight, spontaneous mobility, rec-
tal temperature and hemoglobin, leukocyte, and
erythrocyte concentrations were measured. On day
20, corpora lutea, implantation sites, pre- and post-
implantation deaths, and living fetuses were count-
ed. The sizes and weights of living fetuses were
determined.
Dams exposed to 0.005 mg/l of formaldehyde
exhibited decreased neuromuscular excitability, spon-
taneous mobility, rectal temperature, and hemo-
globin concentration. Exposure to 0.0005 mg/l only
caused a slight increase in lymphocytes.
At sacrifice on day 20, the number of preim-
plantation deaths washigherinboth groups exposed
to formaldehyde than it was inthe controls. Interest-
ingly, the numberoflive fetuses was approximately
the same in all groups. No external malformations
were observed in the offspring.
Six dams from each group delivered offspring on
day 22; all progeny appeared to be normal at birth.
At one month postpartum, the female offspring
from control dams were larger than the female
offspring from treated dams. For male progeny,
the opposite was true. At one month, the spontane-
ous mobility ofprogeny from treated dams was less
than that of control progeny. By two months, the
hemoglobin and leukocyte concentrations were de-
creased in progeny of dosed dams but not in a
dose-related manner.
Guseva (39) studied the gonadotropic effects of
formaldehyde by measuring testicular nucleic acid
content in rats. During a 6month treatment period,
3 groups ofmale rats were subjected to a combined
action of formaldehyde orally (in drinking water)
and by inhalation. Group 1 received formaldehyde
at a concentration of0.1 mg/l in drinking water and
by inhalation at a level of 0.5 mg/mi. Group 2
received formaldehyde at a concentration of 0.01
mg/l and by inhalation at a level of 0.25 mg/m3.
Group 3 received formaldehyde at a concentration
of 0.005 mg/l and by inhalation at a level of 0.12
mg/m3. Group 4 served as untreated controls. Treat-
ment in the drinking water was continuous and
simultaneous exposure to formaldehyde by both
routes occurred five times per week for 4 hr each
time. Reproductive function was evaluated by pair-
ing each treated male with two virgin untreated
females. Although the number of males was not
Environmental Health Perspectivesspecified, the use of six females per group implies
the use ofthree males in each group. On day 20, an
unspecified number ofpregnant females were killed
and their offspring were removed and examined.
Guseva failed to mention the results of the exami-
nation of the fetuses. The remaining dams were
allowed toproduce offspring. Thenumberandweight
of newborn rats were recorded. Observations of
their subsequent development extended over one
month. The time of eye opening and other devel-
opmental indices were recorded for the offspring of
males in groups 1 and 3 only.
The capacity of the treated males to produce
offspring was not diminished. There was no effect
on the weight of the fetuses or the size of the
litters. The offspring were morphologically normal
at birth and developed normally thereafter. Gon-
adotrophin levels were not significantly different
between males in the control group and those in the
treatment groups. However, the amount ofnucleic
acid in the testes of males of groups 1 and 2 was
significantly less than the amount in the testes of
the controls.
Sanotskii et al. (40) studied the effects offormal-
dehyde on reproduction in an unspecified strain and
number of albino rats. They exposed groups of
pregnant and nonpregnant rats to 0, 0.4 or 6.0
mg/m3 of formaldehyde for 4 hr/day for 20 days.
Evaluations were made of body weight, nervous
system function, renal function, hepatic function,
and biliary levels of cholic acid. Blood parameters,
oxygen uptake, and rate of respiration were mea-
sured.
Nonpregnant animals were more susceptible to
the effects of formaldehyde than were pregnant
animals. Formaldehyde at 6.0 mg/m3 resulted in
altered renal function as shown by decreases in
daily diuresis and urinary chlorides and an increase
in urinary protein concentration. The increase in
urinary protein may have reAected decreased uri-
nary output. Altered hepatic function was mani-
fested by adecrease inurinary excretion ofhippuric
acid. At6.0mg/m3, onlybloodhemoglobindecreased
inthe pregnant rats. Exposure to 0.4 mg/m3 did not
produce toxic changes in either pregnant or non-
pregnant rats.
All the studies suffered from an unreported or
inadequate number of animals treated per dose
level. In the teratology studies, detailed results
from skeletal and soft-tissue analyses were miss-
ing. None ofthe studies had a sufficient number of
dose levels to fulfill current requirements. Even
with these deficiencies, there were indications that
formaldehyde might affect reproductive potential
by altering testicular nucleic acids and by increas-
ing pre-implantation losses.
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Dietary Studies. Hurni and Ohder (41) studied
the effects of formaldehyde on reproduction in the
beagle. Groups of 9-11 pregnant bitches were fed
dietary levels of600 or 1250 ppm HMT, or of 125 or
375 ppm formaldehyde, from 4 days after mating to
day 56. Eleven controldogs ateunadulterated chow.
The bitches were weighed weekly. The pups were
weighed at birth and twice weeklythereafter. They
were inspected forvisible defects immediately after
birth and at 8 weeks postpartum. Stillborn pups
and those that died before weaning were autopsied
and examined for internal and skeletal anomalies.
Neitherformaldehyde nor HMT affected the preg-
nancy rate. Maternal body weights increased nor-
mally during pregnancy in all groups. The duration
of gestation was not affected by formaldehyde or
HMT. Mean litter sizes were within the normal
range for all groups. In the group that received
1250 ppm of HMT, there was a greater percentage
of stillborn pups than in any other group; this was
mainly due to one litter in which 7 of 9 pups were
dead. The stillborn pups were not malformed.
During the first month, the pups from bitches
given 1250 ppm HMT grew less than normal. The
retarded growth coincided with increased mortali-
ty. In the same group, the percentage of pups that
survived to weaning was lower than it was in the
other groups. All the dogs that were observed for
up to 9 months exhibited normal behavior, appear-
ance, mobility, and muscular coordination.
Natvig, Andersen and Rasmussen (42) studied
the effects of HMT fed to Wistar rats. Two groups
of 16 male and 16 female rats each were fed a diet
containing 0.0 or 0.16% HMT starting at 2 months
of age and continuing for three months, when they
weremated with group mates. Theiroffspringwere
fed the same diet. The offspring were weighed at 7
and 15weeks, measured forvoluntary muscle activ-
ity at 6 weeks, and killed when they were 123 days
old. Half of them were autopsied.
There were no detectable differences between
the test and control groups. The fertility of the
treated animals was similar to that of control ani-
mals. The offspring from both groups had similar
muscular activity, body weights, general health
and organ weights.
For the purpose of clarifying the teratogenic
potential offormaldehyde, it is unfortunate that in
both of these studies the dams were allowed to
deliver naturally. Removing all the pups by cesar-
ean section would have permitted detailed exami-
nation for anomalies. By allowing the dams to lit-
ter, it was possible that the malformed pups were
eaten by the mother before being seen by the
investigator. Neither report states if an observer
was present at all deliveries. Although teratogenic
145effects were not noted, HMT appeared to have
fetotoxic and postnatal effects in the beagle at 1250
ppm (31 mg/kg). In the rat study, additional dose
levels would have been desirable.
Intubation Studies. Marks, Worthy and Sta-
ples (43) intubated pregnant outbred albino mice on
days 6-15 of gestation with 1% aqueous formalde-
hyde at levels of 0, 74, 148, or 185 mg/kg/day. On
day 18, the mice were killed and the offspring
examined. All mice were coded in a manner that
prevented laboratorypersonnelfromknowingwhich
ones belonged to the control and test groups. Vis-
ceral observations were made by the Staples tech-
nique and all fetuses were examined for skeletal
anomalies.
Formaldehyde was toxic to 22 of 34 pregnant
miceat185mg/kg. At74mg/kg, therewasasignificant
decrease in average weight gain during pregnancy.
Formaldehyde treatment, at any dose level, did not
result in malformations.
Although formaldehyde caused toxicity in preg-
nant mice, it was not teratogenic. Because of the
methods employed and the number ofanimals used
at each level, this appears to be a valid, reliable,
and negative teratogenic study of orally adminis-
tered formaldehyde.
Drinking Water Studies. Della Porta, Cabral
and Parmiani (44) conducted several studies on the
effects of HMT in rats and published results in a
single manuscript.
Inthe short-termreproduction andtoxicityexper-
iment, 12 females and 6males were given a solution
of 1% HMT in the drinking water, beginning at 8
weeks of age. Two weeks later, the animals were
mated (2 females: 1 male) and treatment of the
females was continued during pregnancy and nurs-
ing. Twenty-four males and 24 females were ran-
domly selected from the progeny and treated as
above until 20 weeks post partum. Each animal was
weighed weekly. At the end of treatment, the
animals weresacrificed, theirorgans wereweighed,
andhistologicalexaminations wereconducted. Groups
of 12 untreated dams and 48 pups were used as
controls.
All treated females and 11 of 12 control females
became pregnant and produced 124 and 118 off-
spring, respectively. The progeny of the treated
femaleswerenotmalformed. Themeanbodyweights
ofthe treated males and females were significantly
less than those ofcontrols. These differences lasted
up to 9weeks formales and to 13weeks forfemales.
After these times, body weights became compara-
ble to the control values. When the offspring were
autopsied at 22 weeks, no microscopic or macro-
scopic lesions were seen. Body weights and organ
weights (liver, kidneys, spleen, thymus, pituitary,
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adrenals and testes) were similar for treated and
control groups.
In the second experiment, two females and one
male were given a solution of 1% HMT in the
drinking water before mating. The treatment of
females continued until two litters of 10 rats each
had been weaned. Treatment of the F1 progeny
continued until they were 40 weeks of age. To
produce an F2 generation, seven F1 females were
mated with three F1 males at 26 weeks of age. F2
animals were mated at 15 weeks of age to produce
an F3 generation. F1 and F2 animals were given
HMT until the 40th week postpartum; F3 animals
were given HMT to the 20th week. F1, F2 and F3
animals were observed for 130 weeks (2.5 years).
All survivors were sacrificed when they reached 3
years of age.
The survival rates of all the generations of off-
spring were not affected by treatment. Mean body
weights, obtained many times during the experi-
ments, showed no significant differences between
control and treated groups.
In another study, five adult female rats were
bred and treated with 2% HMT in the drinking
wateruntil49offspringwereweaned. The offspring
were treated with 2% HMT until they were 50
weeks ofage. After treatment, the survivors were
observed until 130weeks ofage. Rats (48males and
48 females) from a previous study served as con-
trols; they were observed untilthey were 3 years of
age. Mean body weights were not significantly dif-
ferent between treated and control animals.
All three studies lacked a sufficient number of
animals per dose level and number ofdose levels to
permit a meaningful evaluation of the potential of
HMT to affect reproduction of fetal development.
The third study also lacked appropriate concurrent
control animals.
Reproduction and Teratology Studies
in Humans
Shumilina (45) studied the reproductive potential
of women who were exposed to formaldehyde. In
the study, the menstrual and reproductive func-
tions of 446 women were evaluated in two experi-
mental groups. The first group of 130 women were
fabric trim shop finishers. The second group of316
women were fabric warehouse inspectors. A third
group of200industrial goods saleswomen who were
not exposed toformaldehyde were used as controls.
The trim shop finishers worked in atmospheric con-
centrations offormaldehyde rangingfrom 1.5 to 4.5
mg/i3. The warehouse inspectors worked where
formaldehyde concentrations varied from 0.3 to 0.7
mg/m3 in one shop and from 0.05 to 0.1 mg/m3 in
Environmental Health Perspectivesanother shop. All womenwere given complete med-
ical examinations.
Menstrual disorders were found in 47.5% of the
women exposed to formaldehyde as compared to
18.6% of the controls. Dysmenorrhea was found in
24.3% of the finishers as compared to 9.2% of the
controls and 20.2% of the inspectors. It occurred
more frequently inthe31-40year-oldwomen(20.7%
in the experimental group versus 6.7% in the con-
trols). A cause ofthe painful menstruation was not
found. Hypomenstrual syndrome occurred in 1.2%
of the finishers with less than 5 years of potential
exposure to formaldehyde, in 47% with 6-10 years
of potential exposure, and in 6.8% of cases with
more than 10 years of potential exposure. More
menstrual disorders were found in workers below
30 years of age (33.4%), but fewer disorders were
observed in persons aged 30-40 years (20.8%).
The incidence of inflammatory diseases in the
reproductive tract among trim shop finishers was
38.2% and among the warehouse inspectors it was
25.1%. Both ofthese values were greater than the
control value (p < 0.05). The percentage ofwomen
with exposure to formaldehyde who had primary
sterility was 5.2; this value may be compared to
2.5% incidence in the controls. The incidence of
secondary sterility was 15.3% in the finishers, as
compared to 6.5% in the controls. The high inci-
dence ofsecondary sterility in exposed women may
have been due to previous inflammatory diseases.
The number ofterm deliveries and artificial abor-
tions did not differ significantly among the groups
ofworkersinvestigated. Anemia, themostfrequent
complication of pregnancy, occurred twice as often
in women exposed to formaldehyde, as it did in
control women. The hazard ofintrauterine asphyx-
iation of the fetus was also encountered twice as
often in the exposed women as inthe control group.
The percentage of children with low birth weights
was greater in women exposed to formaldehyde
than it was in the control women.
Menstrualdisorders werefoundinwomenexposed
to formaldehyde. Although the number of term
births and artificial abortions did not differ among
the groups, there were increases in primary and
secondarysterility, anemia, andintrauterine asphyx-
iation of the fetus among women exposed to form-
aldehyde. Though these data have many limita-
tions, they raise the possibility that formaldehyde
may affect human reproductive processes. Addi-
tional research is needed to confirm these effects.
Reproduction-Related Studies
Palkovits and Mitro (46) studiedformalin-induced
stress in neonatal rats. They injected one group of
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newborn Wistar rats with 0.02 ml of2% formalde-
hyde IP once on the day of birth. A second group
was injected daily for the first 4 days after birth.
Control animals were untreated. At 24 hr after the
last injections, all neonates were decapitated. The
adrenals and hypothalamus were examined micro-
scopically.
In the neonates injected for 4 days, degenerative
cellularatrophy occurred inthe ventro-medial arcu-
ate of the hypothalamus. Single injections ofform-
aldehyde did not cause degenerative changes but
did cause decreased cellular activity in the medial
field of the ventromedial nucleus and the arcuate
nucleus and an accumulation of granules in the
neuronal cytoplasm. In both groups, formaldehyde
injections increased nuclearvolume in the adrenals.
These changes indicate that the hypothalamus of
the neonatal rat is sensitive to corticoid feedback
induced by formaldehyde administration.
Cohen (47) studied the response to formaldehyde
injection in fetal rats by measuring ascorbic acid
levels in the adrenals. Pregnant female rats were
anesthetized with ether and delivered by cesarean
section. The first fetus from each litter served as
the control. Approximately 6 Rl/g of 2% formalde-
hyde were then injected SC into one or more litter
mates. Fetuses were injected with formaldehyde at
18.5, 19.5, 20.5 or 21.5 days of gestation.
Injections offormaldehyde resulted in decreased
ascorbic acid levels in the adrenals at 20.5 days of
gestation. Injections on other days ofgestation did
not cause this response in fetuses.
Conner et al. (48) studied the effects offormalde-
hyde injected into the uterus of pregnant rats.
They were interested in its potential as a con-
tragestational agent. On day 3 or day 7 after mat-
ing, they injected 0.05 ml of formaldehyde (40, 10,
7, 3.5, 2.0, 0.5, 0.05 or 0.0005%) into one uterine
horn and 0.09% saline into the other horn (control)
of 3-5 pregnant Sprague-Dawley rats/group. All
solutions of formaldehyde also contained 12-15%
methanol. On day 15, dams were sacrificed, and the
numberofcorpora lutea, viable fetuses, and resorp-
tions were counted.
Injections of40 and 10% formaldehyde produced
maternaltoxicityanddeath. Injectionsof7.0through
0.5% on day 3 terminated most pregnancies. When
these concentrations were injected on day 7, most
pregnancies continued. The authors concluded that
the contragestational properties of formaldehyde
were similar to those of other protein denaturing
agents, includingethanol, methanoland silvernitrate.
Because methanol solutions alone were not tested,
contragestational effects of methanol could not be
clearly distinguished from those offormaldehyde.
These physiological and endocrine studies are
147interesting but their relation to the teratogenic
potential of formaldehyde is unclear.
Dominant Lethal Studies
Epstein et al. (49) tested formaldehyde for muta-
genicity by the use ofthe modified dominant lethal
test. Male ICR/Ha Swiss mice were given a single
dose of 16, 20, 32 or 40 mg/kg of formaldehyde IP.
After dosing, each male was placed with three
females weekly for 3 weeks. Alternatively, male
ICR/Ha Swiss mice were given dose levels of 16 or
20 mg/kg IP and placed with three females weekly
for 8 weeks. At the dose levels tested, formalde-
hyde did not produce an increase in early fetal
deaths or pre-implantation losses.
Formaldehyde did not appear to affect sperma-
togenesis or fertility in mice at the dose levels
tested in this study.
Recommendations
Teratology. The data are inadequate to demon-
strate whether or not formaldehyde is teratogenic.
Thepanel's surveyrevealed only onewell-conducted
study and that was done by oral administration in
mice (43). Recommendations are that teratology
studies should be performed in rats and rabbits and
that these studies should include the administration
of formaldehyde by inhalation.
AnimalReproduction. ThestudyofDellaPorta
et al. of HMT (44) lacked the proper number of
animals per group needed to evaluate reproductive
andteratogeniceffects. Multigenerationstudieswith
a larger number of animals should be conducted to
test the effects of formaldehyde on reproduction.
Although the physiological and endocrine studies
contribute to an understanding ofthe reproductive
effects of formaldehyde, many questions remain
unanswered. Mechanisms of biochemical changes
and teratology cannot be elucidated until additional
biochemical and pharmacological studies are done
including placental transfer studies.
Human Reproduction. Shumilina's study (45)
revealed several possible effects of formaldehyde
onhumanreproduction, butthestudylackssufficient
data to answer the questions it raises. Controlled
epidemiological studies should be conducted.
Mutagenicity
In a review of the extensive literature on the
genetic toxicology offormaldehyde by Auerbach et
al. (50), the results of experiments on formaldehyde-
treated food in Drosophila are discussed as well as
data obtained by exposure of other organisms to
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vapor or aqueous solutions offormaldehyde and by
combinationtreatments withformaldehyde andother
mutagens. Formaldehydetreatmentalonegivespos-
itive but weak responses in many laboratory organ-
isms; both gene mutations and various types of
chromosome aberrations are produced. A briefsum-
mary ofthe genetic effects offormaldehyde has also
been published by Cooper (51).
Genetic Effects of Exposure
Formaldehyde-TreatedFood. The most exten-
sive data (50) have resulted from treatment of
Drosophila with formaldehyde-food (FF). In the
early experiments of Rapoport (52) treatment of
young larvae resulted in an increase of sex-linked
recessive lethals from a control frequency of 0.2%
to about 6%. FF produced all types of gene muta-
tions (both point mutations and deletions) and chro-
mosome rearrangements (small duplications and
deficiencies toinversions and translocations). These
results were independently confirmed by Kaplan
(53). Slizynska (54) comparedthestructuralchanges
induced by FF with those produced by x-rays. In
contrast to 97% translocations or inversions and
fewer than 3% small deficiencies or duplications
induced byx-rays, only30% translocations orinver-
sions and 64% small duplications or deficiencies
were found among FF-induced changes.
Formaldehyde Vapors. Nomutationswerepro-
duced by exposing Drosophila adults for up to 1 hr
or larvae for up to 2 hr to sublethal concentrations
of formaldehyde gas (55).
FormaldehydeSolutions. Earlyexperimentsin
Escherichia coli B (56) showed that formaldehyde
is a very weak agent for the production of point
mutations from streptomycin-dependence to inde-
pendence. Injection of formaldehyde solutions into
adult Drosophila provided an effective means for
inducing sex-linked recessive lethal mutations, but
lower frequencies were found than obtained with
FF (57, 58).
More recent studies have shown that the ability
of formaldehyde to induce forward mutations at
specific loci in the ad-3 region of Neurospora (by
direct treatment at levels producing 75 - 5% surviv-
al)increased from a spontaneous frequency of0.4 x
10- to 4 - 6 x 10- among survivors (59). With this
assay, gene mutations resulting from both point
mutations and multilocus deletions can be detected.
Genetic characterization of formaldehyde-induced
ad-3 mutants is in progress. Formaldehyde was
found to induce point mutation byreverse-mutation
in both Neurospora (60, 61) and Aspergillus (62),
but not in Salmonella (63, 64). The National Toxi-
cology Program has reported that, in recent inves-
Environmental Health Perspectivestigations by three independent laboratories using
the Ames test, formaldehyde tested positively in
one of four bacterial strains (TA 100) that detects
base-pair substitution mutations.
A number of genetic effects have been found in
mammalian cells in culture. These include: (1) an
8-10 fold increase in forward mutation frequency at
the thymidine kinase (TK) locus inmouse lymphoma
cells (65); (2) a 1.5-3-fold increase in the frequency
of sister chromatid exchanges in Chinese hamster
ovary cells and in human lymphocytes in culture
(66); and (3) induction ofunscheduled DNA synthe-
sis in HeLa cells over a dose range of10' - 10e M
(67).
MammalianinvivoStudies. Nodatawerefound
in the literature on the induction ofgenetic damage
in mammals either in somatic cells or germ cells.
Epstein et al. (68) were unable to detect early fetal
deaths induced by formaldehyde injection in an
assay for dominant lethality in mice.
InteractionwithOtherMutagens. InDrosophi-
la, Sobels (69) found that either pre- or post-
treatments with formaldehyde almost doubled the
frequencies of x-ray-induced sex-linked recessive
lethals. InNeurospora, earlyexperimentsbyDickey
et al. (70), Kolmark (71), and Kolmark and Wester-
gaard (72) showed that formaldehyde by itself is
only weakly mutagenic, whereas a mixture ofform-
aldehyde and peroxide gave a much higher effect
than could be predicted on the basis of a strictly
additive effect of the two agents.
Increased Effects in Repair-Deficient Strains.
Nishioka (73) compared the lethality and mutagenic
damageproducedbyformaldehyde inE. coli strains
HCR + and HCR- and found that, in the latter
excision-repair deficient strain, much higher levels
ofeffect were produced. Comparisons ofthe ability
of direct treatment with formaldehyde solutions to
induce specific locus mutations in the ad-3 region of
wild-type and excision-repair deficient, two-com-
ponent heterokaryons of Neurospora have shown
up to a 370-fold higher mutation frequency in the
excision-repair deficient strain (59). The same is
true for excision-repair deficient mutants of Sac-
charomyces cerevisiae (74). In addition, more pro-
nounced genetic effects offormaldehyde were found
with cell lines ofXeroderma pigmentosum as com-
pared with normal human fibroblasts in culture
(75).
Summary
Formaldehyde produces gene mutations and such
chromosome aberrations asdeficiencies, duplications,
inversions, and translocations; no data are available
for the production of aneuploidy. In most experi-
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ments, dose-response relationships could only be
demonstrated with difficulty or not at all, and all
data are consistent with the classification offormal-
dehyde as a weak mutagen. Formaldehyde has
been showntointeract with othermutagens such as
x-rays, ultraviolet radiation and hydrogen perox-
ide, andtoatleastdouble thefrequencies ofmutants
expected from treatment with these agents. Form-
aldehyde effects on both lethality and the induction
ofmutations in microbes are markedly enhanced in
excision-repair deficient strains. No data are avail-
able from studies on mammalian systems in vivo on
genetic effects on germ cells.
Risk Assessment
Since there are no effects reported on mamma-
lian germ cells the genetic risk of exposure to
formaldehyde can only be made by extrapolation
from experiments with otherlaboratory organisms.
The only genetic data relevant for risk estimation
are those for the induction of gene mutations and
chromosome aberrations. There are no data on the
induction of aneuploidy by nondisjunction or any
other mechanism. In this respect, the most exten-
sive data result from experiments with Drosophila
on formaldehyde-treated food. It is not known how
representative these data are ofgenetic effects that
would be expected from exposures to vapors or
solutions. The Drosophiladata showthat 64% ofthe
transmitted chromosomal effects studied resulted
from small duplications or deficiencies, the remain-
derwere due tolarge inversions and translocations.
No data were found which would be useful in deter-
mining whether a comparable spectrum of genetic
alterations would be found with lower chronic lev-
els of exposure. In conclusion, although heritable
genetic damage has been demonstrated, only small
increases would be expected from the levels of
formaldehyde which might reach the germ cells.
The Drosophila data, for example, indicate that
sensitivity is limited to effects on males and is
restricted to early spermatocytes; whether similar
effects can be expected in whole animal systems is
unknown.
Recommendations for Future Studies
The genetic effects offormaldehyde in man could
be more readily predicted if selected experiments
were performed on laboratory animals. Such stud-
ies could begin with an experiment usingthe invivo
mammalian spot test to determine whether formal-
dehyde vapors or solutions would cause gene muta-
tions in somatic cells that affect coat color (76). This
test has the advantage of requiring exposure and
149analysisofprogenyfromonly30-50pregnantfemales.
The test is thus relatively inexpensive and has been
used to evaluate the mutagenic activity of a wide
range of chemical agents.
Inthe event ofapositive resultinthe mammalian
spot test, two additional assays should be applied in
mice: (1) the heritable translocation test (77) and
(2) the morphological specific locus test (78). Con-
siderably more workisinvolved inthesetwo assays
but they are useful to determine, respectively,
whetherheritablechromosomeaberrationsandgene
mutations have been produced. In the presence ofa
negative spot test it is unlikely that positive results
would be found in the latter two tests which detect
genetic effects produced in male germ cells.
Carcinogenicity
The literature search revealed only a few studies
that were designed for the purpose oftesting form-
aldehyde for carcinogenic activity. Because oflimi-
tationsinexperimentaldesign, manyofthereported
studies are inconclusive. In this section only those
studies will be reviewed which were conducted
over a sufficient length oftime to permit detection
of carcinogenic activity activity of the test chemi-
cal. The investigations will be discussed in order of
their importance as judged by this panel, starting
with the inhalation exposure studies.
Review of Formaldehyde
Carcinogenesis Studies
By far the most important carcinogenesis study
conducted to date with formaldehyde is the CIIT
inhalation study recently reported by Swenberg et
al. (79). F344 rats and B6C3F1 mice (120 male and
120 female rats or mice per group) were chronically
exposed to 2.1, 5.6 and 14.1 ppm of formaldehyde
vaporsfor6hr/day, 5days/week. Duringthefirst 18
months of exposure, 2, 2, 8 and 44 rats died in the
groups exposed to 0, 2.1, 5.6 and 14.1 ppm of
formaldehyde, respectively. Of the 44 rats which
died spontaneously in the group exposed to 14.1
ppm, 32 had nasal tumors (28 squamous carcinomas
and four squamous papillomas). Many of the rats
also showed hyperplastic and metaplastic lesions of
the nasal epithelium. Hyperplastic and metaplastic
lesions were also detected in rats exposed to 5.6
ppm formaldehyde (14 lesions were found in eight
rats), indicating that the nasal epithelium was
significantly damaged at this lower level of expo-
sure. At 18 months ofexposure, 40 rats were killed
in each group. Eight of40 rats exposed to 14.1 ppm
haddevelopednasalsquamouscarcinomas. Although
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no carcinomas of the airways were found in the
other groups, one adenomatous polyp was found in
one rat ofeach ofthe groups exposed to 2.1, 5.6 and
14.1 ppm. In addition, a large numberofhyperplas-
tic and metaplastic lesions was detected in the nasal
epithelium of these rats, even at formaldehyde
concentrations as low as 2.1 ppm. No exposure-
related tissue abnormalities were reported at sites
other than the nasal cavities and no exposure-
related neoplasias were reported in formaldehyde
exposed mice, but examination of the animals
sacrificed after 24 months of exposure is not com-
plete.*
One complication noticed during the study was a
spontaneousoutbreakinratsofsialodacryoadenitis.
The evidence for this consisted of decreased body
weight in all dosed and control rat groups at about
the52ndweekoftheexperiment, followedbyprompt
recovery ofbodyweight, and histopathological dem-
onstration oftypical lesions in lacrimal and salivary
glands and in the upperrespiratory tissues ofdosed
and control rats in the 12 month sacrifice groups.
Evidence of sialodacryoadenitis was not found in
rats sacrificed at 6 or 18 months or in those with
unscheduled deaths. Virus isolation, viral antigen
demonstration, and serologic tests for antibodies
were not attempted in rats or mice.
With regard to formaldehyde in the exposure
chamber, apanel ofexpertsreviewed the method of
formaldehydegeneration andmonitoringand"agreed
that the Battelle approach to formaldehyde vapor
generation was a suitable adaptation of accepted
methods and principles and, therefore, was sound
and based upon the best available technology. The
same type ofassessment applied to the chamber air
monitoring system, which also combined two well-
established procedures" (81).
Suggestive evidence for the carcinogenicity of
inhaled formaldehyde vapors also comes from a
study by Laskin et al. (82). One hundred male
Sprague-Dawley rats were exposed to a mixture of
gaseous formaldehyde (14.7 ppm) and hydrogen
chloride (10.6 ppm) for 6 hr/day, 5 days/week for
life. Of the exposed rats, 27% developed nasal
tumors, ofwhich 25 were squamous carcinomas and
*TheChemical Industry Institute ofToxicologyrecentlyreported
results up to and including the 24 months sacrifice, as follows: in
rats exposed at 14.1 ppm there were 93 animals with squamous
cell carcinomas, four with squamous papillomas, three with
adenomatous polyps and two with carcinomas ofthe respiratory
epithelium; at 5.6 ppm there were two squamous cell carcino-
mas, four adenomatous polyps and one carcinoma ofthe respira-
tory epithelium; and at 2.1 ppm, five rats had developed adeno-
matous polyps. Additionally, two mice sacrificed at 24 months
were found to have nasal squamous cell carcinomas (80).
Environmental Health Perspectivestwo were papillomas. No nasal tumors were found
in 100 control rats. Both dosed and control rats had
pneumonia but the lesions were more severe in
dosed rats. The estimated bis(chloromethyl) ether
(BCME) level in the exposure chamber (developing
as a result of the chemical interaction of formalde-
hyde and hydrogen chloride) was 1 ppb. This value
was computed on the basis of 10 measurements
made in the mixing chamber during the course of
the study. It is not certain whether the high nasal
cancer incidence is a result of the formaldehyde
exposure, the (presumed) BCME exposure, or the
biological interaction of the two or three compo-
nents of the gas mixture. Based on their previous
studies (83), the authors considered the BCME
level to be too low to be a significant etiological
factor for the nasal cancers observed in this study.
They also point to the fact that in rats, BCME
caused mostlyesthesioneuroepitheliomas ratherthan
squamous carcinomas in the nasal cavities. While
the results suggest that formaldehyde (rather than
BCME) is the major etiological agent in this exper-
iment, considerable uncertainty remains and other
interpretations are possible. The authors' compari-
son of 20 exposure days at 100 ppb of BCME (83)
with 500 exposure days at 1 ppb ofBCME (82) does
not, however, resolve the uncertainty ofcomparing
the different factors involved in dose-rate versus
total delivered dose in tumor induction.
Three other chronic inhalation studies with form-
aldehyde designed to investigate possible cocar-
cinogenic effects of this agent in the upper and
lower airways have been reported (84-86). Since
the nasal tissues were not systematically examined
histologically, the value of these studies in assess-
ing the carcinogenicity of formaldehyde is accord-
ingly limited. In spite of these reservations, the
studies have some bearing on the problem ofform-
aldehyde carcinogenicity. In the studies conducted
at the Oak Ridge National Laboratory (ORNL) by
Nettesheim and colleagues (84), Syrian Golden ham-
sters were exposed by intratracheal (ITr) instilla-
tion to different doses of benz(a)pyrene (BaP) and
by inhalation to various concentrations of formal-
dehyde (acrolein exposures were carried out in
parallel studies). Two types offormaldehyde expo-
sure schedules were used: 10 ppm for 5 hr/day, 5
days/weekforlife (two groups) and 20 or50 ppm for
5 hr/day, 1 day/week for 17 weeks (seven groups).
Inall, nine groups of88hamsters each were exposed
to formaldehyde (with or without BaP exposures;
two groups were exposed to formaldehyde only).
Significant in the context of this discussion is that
no macroscopically recognizable nasal tumors were
observed in hamsters, whereas in the studies with
rats by Swenberg et al. (79) and by Laskin et al.
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(82), grossly visible tumors developed. Based on
extensive
histopathological evaluation, there was no evidence
forthe carcinogenicity or cocarcinogenicity ofform-
aldehyde forthe larynx, tracheaand lowerairways.
No neoplasms were found in two sections of nose
from each hamster, but the level of sectioning was
not rigorously controlled.
In the study reported by Horton et al. (85), C3H
mice were exposed to coal tar aerosol and/or to
formaldehyde at concentrations of 40, 80 and 160
ppm. Exposures were carried out for 1 hr/day, 3
days/week for 35 weeks, except for the 160 ppm
group which was exposed only for 4 weeks because
oftoxicity. Only 15 mice survived to 1 year. There
is no mention of histopathological evaluation of
nasaltissues, sopresumablynogrosslyvisibletumors
were observed. Coal tar aerosol exposure resulted
in lung tumor formation in five animals (one inva-
sive carcinoma) butformaldehyde exposure did not.
Noevidence wasfoundforanycocarcinogenic effects
of formaldehyde. The major shortcomings of this
study for evaluating the carcinogenic activity of
formaldehyde are that too few animals survived
past one year, the individual exposures were short,
most groups were exposed only for 35 weeks, and
histopathology was inadequately reported.
A third study (as yet unpublished) has been
performed by Dalbey and Nettesheim at the Oak
Ridge National Laboratory (86). Inthis study, male
Syrian Golden hamsters were exposed to diethyl-
nitrosamine (DEN) subcutaneously (0.5 mg once
weekly for 10 weeks) and to inhalation of either
nitrogen dioxide (10ppm) orformaldehyde (30ppm).
Exposures to NO2 and formaldehyde were made
once weekly for 48 hr prior to each DEN injec-
tion and were subsequently continued for lifetime
after DEN injections were completed. An analysis
oftumor data indicated that formaldehyde (but not
nitrogen dioxide) might act as a tumor "enhancing
agent" in the trachea as measured bymultiplicity of
tumors. This study was limited because, at the
doses used, DEN alone produced tumors in a high
proportion of animals.
Thecarcinogenicity offormaldehydehasalsobeen
tested by avariety ofotherroutes ofadministration
including subcutaneous injection (in rats), ingestion
(by mice and rats), uterine cervical application (in
mice) and application to the buccal mucosa (in rab-
bits). Because ofshortcomings in experimental pro-
tocols, none of these studies permits firm conclu-
sionsregardingfornaldehydecarcinogenicity. None-
theless, some ofthe studies give definite clues that
formaldehyde may be carcinogenic to a variety of
target tissues as well as a variety ofanimal species
(and not only to the nasal epithelium ofrats).
151The most revealing study in this regard is that by
Mueller et al. (87), who applied a solution of 3%
formalin to the oral mucosa of rabbits, using an
"oral tank." Each exposure lasted for 90 min and
was repeated five times per week for a period of 10
months. As a result, two out of six rabbits devel-
oped grossly visible leukoplakias that, according to
the authors, showed histological features of carci-
noma in situ. Unfortunately, the information given
onthehistomorphology ofthelesionsisveryscanty.
Nevertheless, the reported observations appear to
be consistent with the rat inhalation studies, sug-
gesting that formaldehyde is a carcinogen.
Also ofconsiderable significance are the observa-
tions reported by Brusick et al. (88) concerning the
transformation of mouse Balb 3T3 cells in vitro by
formaldehyde concentrations as low as 0.5 ,ug/ml
culture fluid. At this time, no other pertinent infor-
mation is available on these studies.
Probably the earliest experiments which suggest
that formaldehyde is a carcinogen are those by
Watanabe et al. (89, 90), who injected rats (strain
unknown) subcutaneously with 0.4% formalin (1
ml/week for 15 months) (89) and with 9-40% of
hexamethylenetetramine (HMT) (from which form-
aldehyde is liberated in vivo) 1-2 ml per week until
tumor development (90). In the first study (89),
four of ten rats developed sarcomas at the site of
the injection, and in the second study (90), eight out
of 20 rats developed tumors, seven sarcomas and
one adenoma. There is little doubt that tumors
were induced by the subcutaneous injections of
both chemicals over many months. It is not certain,
however, what the role of the repeated severe
injury to the subcutaneous tissue may have been in
the induction ofthe sarcomas even through results
with formic acid were negative (90).
Several other studies carried out with HMT
resulted in negative findings. Brendel (91) adminis-
tered HMT daily by gavage to 15 male and 15
female BD rats (0.4 g/day) for 333 days. No treat-
ment-related tumors were observed. Della Porta et
al. (92) administered HMT in the drinking water to
CTM, SWR and C3Hf mice (1.25-12.5 g/kg body
weight/day for up to 60 weeks) and to Wistar rats
(1.5-2.5 g/kg body weight/day for 104 weeks). No
treatment-related tumors were observed. Also neg-
ative was a subsequent study in which Wistar rats
were given 2% HMT in the drinking water over
three consecutive generations (44). No evidence for
transplacental carcinogenicity was found. It seems
clear that, in contrast to long term repeated subcu-
taneous administration in rats, chronic ingestion of
HMT was not carcinogenic to rats and mice. A
study by Klenitzky (93) in which "formol oil" was
applied 50 times to the cervix uteri of mice (strain
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unknown) resulted in no tumors. It is difficult to
interpret this experiment, however, because no
information is available on the nature of the mate-
rial used or on the quantities applied.
Discussion of Laboratory Findings
At present only one study unequivocally demon-
strates the carcinogenicity offormaldehyde. This is
the study by Swenberg et al. (79) which showed a
nasal tumor incidence of20% in rats killed after 18
months exposure to 15 ppm offormaldehyde vapors
(the cumulative cancer incidence in the 24-month
exposure study is presently not known). No ex-
posure-related tumors have as yet been found in
mice which were simultaneously exposed to the
same concentrations of formaldehyde. In order to
clarify the significance and validity of the CIIT
study which, so far at least, appears to be unique in
its clear demonstration offormaldehyde carcinoge-
nicity, we will discuss a series ofquestions which it
raises.
(1) Is there any other evidence supporting the
results obtainedbySwenbergetal. (79)?Theanswer
is yes. In the study reported by Laskin et al. (82),
rats exposed to formaldehyde, hydrogen chloride,
and BCME developed nasal squamous cell carcino-
mas. There is reason to believe that formaldehyde
was a major, if not the only, etiological factor (see
above). There is evidence that both formalin and
HMT (which releases formaldehyde in vivo) cause
sarcomas in rats when injected repeatedly over
long periods of time (89, 90). It has been reported
that exposure of the oral mucosa of rabbits to
formalincausesadvanced preneoplasticlesions (car-
cinomainsitu)(87). Fonnaldehydehasbeenreported
to cause transformation invitro in amammalian cell
line (88). Formaldehyde has been shown to be
genotoxicinmanydifferent testsystems (see section
on formaldehyde mutagenesis). A closely related
aldehyde, namely acetaldehyde, was recently re-
ported to cause nasal cancers (5%) and laryngeal
cancers (14%) in hamsters chronically exposed by
inhalation to 1650-2500 ppm for 52 weeks (7 hr/day,
5 days/week) (94).
(2) Is the carcinogenicity of formaldehyde re-
stricted to only one species, the rat, and only one
tissue, the nasal mucosa? Several references cited
above suggest that it is not. Species otherthan rats
and tissues other than nasal epithelium seem to be
susceptible to the carcinogenic activity of formal-
dehyde. However, considerable differencesindegree
of susceptibility may indeed exist. Lesions inter-
preted to be carcinomas in situ were induced in the
oral mucosa of rabbits (87). Sarcomas were pro-
duced by repeated SC injections of formaldehyde
Environmental Health Perspectivesand HMT into rats for many months (89, 90). Neo-
plastic transformation of mouse Balb/3T3 cells in
culture has been demonstrated (88). Chronic inha-
lation of the closely related short chain aliphatic
aldehyde, acetaldehyde, has been reported to cause
not only nasal but also laryngeal carcinomas in
hamsters (94).
The nature ofthe differences in species suscepti-
bility is not clear (such differences exist, however,
with almost all carcinogens); they could arise at
variouslevelsoforganization(physiological, defense
mechanism, pharmacokinetics, metabolism, repair
capacities). An interesting parallel is the relative
resistance of hamsters to BCME as compared to
rats (83).
(3) Why is the nasal mucosa seemingly the only
targettissueinratsforthecarcinogenicity ofinhaled
formaldehyde? Nasal mucosa is directly exposed to
formaldehyde and may receive the highest dose
althoughdifferencesintissuesensitivity andmetab-
olism might also be involved. It should be men-
tioned that formaldehyde is not the only chemical
carcinogen affecting the nasal mucosa. Other car-
cinogens, in addition to BCME, (including systemic
ones) also cause nasal tumors of susceptible hosts,
for example, various nitrosamines as well as diox-
ane and ethylene dibromide (95). The experimental
induction of nasal tumors in laboratory animals is
thus not a rarity and does not necessarily involve
direct contact, through inhalation, with the nasal
mucosa of the test compound.
(4) Is the viral infection which was noted in the
CIIT study likely to be a significant factor in the
nasal tumor development of the formaldehyde ex-
posed animals? The possibility that the infection
(presumably caused by a corona virus) contributed
to the carcinoma response in this study cannot be
discounted, but the panel considered it unlikely,
because the signs of infection occurred during a
very short portion of the experiment (at most a
week) and the first detected nasal tumors had prob-
ably already formed at the time of the infection.
Although the outbreak ofsialodacryoadenitis intro-
duced anuncontrolled variable intothe experiment,
itisunlikelythatthetransient viralinfection affected
the outcome of the experiment. It is important to
consider that people exposed to formaldehyde may
also experience viral infections of the upper respi-
ratory tract.
(5) Are the irritanteffects offormaldehyde likely
to contribute to its carcinogenicity? "Irritation" is a
poorly defined term. As Berenblum pointed out
long ago, this term is "a vague generalization rep-
resenting many different kinds ofinjury or stimula-
tion ofthe tissues" (96). A more specific effect that
has been included under the generic term of"irrita-
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tion"istheinductionofepithelialhyperplasia. Many
studies on this topic estimate the degree of irrita-
tion by the level of hyperplasia induced in target
tissues. The role of irritation in carcinogenesis has
been investigated since the early years ofchemical
carcinogenesis research (96).
More recent studies have provided evidence on
the hyperplastic effects of several agents, and in
some cases have provided qualitative and quantita-
tive analyses of the tissue response. A number of
agents were reported to induce epithelial hyperpla-
sia in several types of tissues but they had no
carcinogenicortumor-promotingactivityassociated
withthem (97-99). The panelfound noevidencethat
the induction of irritation or, more specifically, of
epithelial hyperplasia is a sufficient condition for
the carcinogenic activity of an agent.
Thereis, however, suggestiveevidencethatsome
agentsthat produce epithelial hyperplasiamayplay
a role in the process of tumor promotion. It was
found that previously initiated mouse skin exposed
to a promoting agent for only a short time will
develop a low level of tumor response. A high
incidence of tumors may develop, however, when
the short period ofexposure tothe promotingagent
is in turn followed by exposure to an otherwise
inactive irritant such as turpentine (100) or wound-
ing (101). Repeated mechanical skin abrasion was
recently found to have a promoting effect on mouse
epidermis (102). It is therefore conceivable that the
"irritant" effectofformaldehyde, ormorespecifically
its induction ofepithelial hyperplasia, may contrib-
ute to some extent to the expression ofits carcino-
genic activity through a mechanism enhancing the
promoting or tumor growth stage of carcinogene-
sis. However, it must be added that our knowledge
ofthistype ofeffect is still quite inadequate and not
directlyapplicable tothereportedcarcinogeniceffects
offormaldehyde on the nasal mucosa.
(6) Are the cytotoxic effects of formaldehyde
likely to be an important aspect of its carcinogenic
activity?Mostcarcinogenshavesignificantcytotoxic
effects. Therefore, formaldehyde is not an unusual
case. There are many reasons why cytotoxic agents
which cause cell death and regenerative cell repli-
cation might enhance the carcinogenesis process:
they increase the number ofcells undergoing DNA
synthesis [it is known that cells are particularly
susceptible to malignant transformation prior to
DNA synthesis at the onset of the DNA-synthesis
phase of the cell cycle (102); they may force the
carcinogen exposed target cells through the several
cell divisions that seem to be required for "fixation"
of the mutagenic or carcinogenic event (104); they
may create selection pressures intissues containing
initiated cells favoring their proliferation and prop-
153agation (105); and they may act as tumor promoters
(106). In short, it is conceivable that the cytotoxic
effects of formaldehyde may play a part in its
overall carcinogenicity.
Conclusions
In assessing the current evidence for the carci-
nogenicity of formaldehyde in animals provided by
the limited number of studies conducted to date,
the panel comestothe followingconclusions: (1) The
CIIT study provides adequate evidence that inhala-
tion of formaldehyde vapors causes nasal carcino-
mas in rats. (2) There is suggestive evidence that
formaldehyde might be carcinogenic in other spe-
cies and tissues other than nasal. (3) Formalde-
hyde should be presumed to pose a carcinogenic
risk to humans.
Recommendations for Future Research
The following are recommendations for future
research on the carcinogenicity of formaldehyde:
(1) the pharmacokinetics of formaldehyde and its
interaction with target tissue should be studied in
several animal species; (2) studies offormaldehyde
by other routes ofadministration (oral and dermal)
should be initiated; (3) additional studies of neo-
plastic transformation ofmammaliancells inculture
are needed.
Epidemiology
Strengths and Weaknesses of
Epidemiologic Methods
Epidemiologic methods for etiologic studies are
designed to uncover disease and exposure relation-
shipsinhumanpopulationswhereinthestudygroups
cannot be experimentally manipulated. Individual
studies must be evaluated in terms ofthe strengths
and weaknesses ofthe studydesign, the summation
ofepidemiologic evidence from a variety ofstudies,
however, requiresdifferentstandards. Circumstances
that allow an exposure associated with a disease to
be judged a cause of the disease have been best
described by Hill (107). First is the strength ofthe
association. Second is the consistency ofthe obser-
vation. The evidence for causality is more persua-
sive when the association has been repeatedly
observedundervariouscircumstancesbyindependent
investigators using different methods. Third is the
specificity oftheassociation. When aspecific exposure
is associated with a certain disease, there is a
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strong argument for cause and effect. In light of
multicausation of most diseases, however, the lack
ofspecificity does not irrevocably discount A causal
hypothesis. Fourth is the temporal relationship of
the exposure and disease. Cross-sectional and case
control studies are poorly equipped to settle this
issue. Fifth is evidence ofadose-response gradient.
Sixth is the plausibility and coherence ofthe hypoth-
esis. Thehypothesisshouldnotconflictwithgenerally
accepted medical theory.
Completed, ongoing, and proposed epidemiologic
studies discussed in thisreportmustbe individually
evaluatedaccordingtothestrengthsandweaknesses
of their design. Conclusions regarding an etiologic
role for formaldehyde in disease processes must be
drawnwhile consideringfindingsagainstHill's (107)
points.
Review of Completed Studies
Information on acute and chronic health effects of
formaldehyde in humans comes largely from the
following two sources: case reports of individuals
who were exposed to formaldehyde and cross-
sectional studies in which measurements of cause
(formaldehyde exposure) and effect (prevalence of
symptoms, signs, and disease) were made at the
same point in time. In addition, limited information
is available from cohort and case-control studies in
which the ascertainment of cause and effect relate
to two different points in time.
In this report, the assignment ofpublished stud-
ies into the above categories was made mainly to
facilitate discussiononproblemsandstrengthsasso-
ciated with each category. For the purpose of this
report, acute effects were defined as those that
developrapidlyafterasingleexposure, whilechronic
effects were considered those that do not become
manifest immediately after exposure and that per-
sist over a period of time. The acute health effects
of formaldehyde have been well documented else-
where (108-110). Therefore, individual studies report-
ing acute health effects of formaldehyde were not
reviewed in detail.
Case Reports
Numerous case reports of health effects, pre-
sumably due to formaldehyde, are available. Con-
tact urticaria was described in a28-year-old woman
who worked as a carver and model setter in a
factory that made leather dresses containing small
amounts of formaldehyde (111). She had urticaria
almost daily, (severely on the hands, with occa-
sional edema ofthe lips) during work days. During
weekends and vacations, when she had no contact
Environmental Health Perspectiveswith the leather, there was no evidence ofthe skin
erruption. Similarly, Harris (112) described four
persons who developed acutepapulovesicular eczema
following contact with urea-formaldehyde resins.
The condition persisted until the workers were
reassigned to areas without formaldehyde.
Sakula (113) reported a case of acute respiratory
distress in a hospital laboratory technician follow-
ing exposure to formalin. Severe bronchial asthma
followed the slightest inhalation of formalin vapor,
but the worker was free from attacks on weekends
and holidays. Acase ofpneumonitis followingheavy
exposure to formaldehyde by inhalation has been
reported (114). The case involved a 27-year-old
neurology resident who spent 15 hr exposed to a
high concentration of formaldehyde vapor during
preparation of brain specimens for student demon-
strations. The following week, after only 2 hr spent
at the same activity, he developed acute respira-
tory distress including progressive dyspnea and
chest tightness over a period of 15 hr. Chest x-ray
showed increased interstitial markings with early
edema. A decreased pulmonary function as mea-
sured by FVC, FEV1.0 and MMEF was also noted
on day 2 and day 24 after the onset of symptoms.*
This is said to be the first report describing a
clinical picture of acute pneumonitis in man follow-
ing formalin inhalation.
Cross-Sectional Studies
Acute Effects. Most of the information on the
acute health effects of formaldehyde comes from
cross-sectional studies ofworkers, volunteers, and
residents exposedtoformaldehyde. Symptoms asso-
ciated with formaldehyde exposure include eye,
nose, and throat irritation leading to lacrimation,
sneezing, shortness of breath, sleeplessness, tight
chest, nausea, and excess phlegm (115-121). An
outbreak of hemolytic anemia among patients on
hemodialysis was described inarecent report (122).
The outbreak occurred shortly after a new system
using filters impregnated with formaldehyde resins
wasinstalled. Whenthefilterswereremoved, hema-
tocrit valuesreturned to previous levels. The sever-
ity and incidence ofsome responses were related to
theconcentration ofexposure. Inaddition, the extent
of reported discomfort appeared dependent on the
relative humidity and temperature of the ambient
air (115, 117, 123).
At 0.1-3 ppm, most people experience an irrita-
tion of the eyes, nose, and throat (115, 117, 123).
Effects of exposures at higher levels are not clear;
with increasing concentration, however, the dis-
comfort increases rapidly and many people can
tolerate exposures of4 to 5 ppm for only 10-30 min
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(124). Between 10 and20ppm, symptoms are severe,
and it becomes difficult to take a normal breath.
Exposures at 50-100 ppm and above may cause
serious injury to the respiratory tract, such as
pulmonary edema and pneumonitis (124).
ChronicHealth Effects. Chronic health effects
attributed tofornaldehyde fromcross-sectional stud-
ies include respiratory problems, dermatitis, neuro-
logic difficulties, and menstrual and reproductive
disorders. Schoenberg and Mitchell (120) studied
five groups ofemployees fromafilter-manufacturing
plant to determine adverse effects of exposure to
phenolic(phenol-formaldehyde) resinfumes. Groups
currently exposed to phenolic resins showed an
excess of chronic cough and/or phlegm when com-
paredtopreviouslyexposedor"never-on-line"groups.
In addition, after adjustments were made for dif-
ferences in total cigarette consumption, workers on
the present production line more than five years
had a significantly lower FEV1.O/FVC and MEF
50%/FVC ratio (p S 0.05) than the "never-on-line"
group. These results suggest that long term expo-
sure to phenol-formaldehyde resin fumes may lead
to chronic airway obstruction. No systematic mea-
surement offormaldehyde concentration was made
during this study but, based on measurements by
others, levels were estimated to be in the range of
0.4 to 0.8 ppm. Exceptionally high levels (8.8 to
13.5 ppm) occasionally occurred when cross-current
fans were turned off during part of the sampling
period. In this study every control subject was
occasionally exposed to resin fumes, which may
explain the high prevalence ofacute symptoms such
as eye irritation (80%), nose irritation (53%), and
lower respiratory tract symptoms (47%) among
"never-on-line" workers. Shift studies suggested a
small reduction in lung function in the production
line workers, whereas control workers showed a
small increase. As noted by the authors, the limita-
tions ofthis studyinclude smallnumbers ofexposed
subjects, probable formaldehyde exposure among
some controls, and the potential for selective bias
commonly associated with cross-sectional studies.
In addition, the possible role of the parent resins,
phenol, and other exposure from the industrial
process, such as acrylic fiber break-down products,
prevents acleardeterminationthatlong-termexpo-
sure to formaldehyde may lead to chronic airway
obstruction.
In a study ofrubber workers exposed to hexam-
ethylenetetramine-resorcinol (HR) resins, Gamble
et al. (125) found more self-reported symptoms
*FVC = forced vital capacity, FEVy.0 = one-second forced
expiratoryvolume, MMEF = maximalmid-expiratory flowrate,
same as mean forced expiratory flow during the middle half of
the FVC (FEF 25-75%).
155(itch, rash, cough, chest tightness, burning eyes,
running nose, and persistent cough and phlegm)
among HR-exposed than among nonexposed work-
ers. Contrary to the previous findings (120), there
were no differences in lung function at baseline
among exposure groups. There were, however,
significantdifferencesinlungfunctionmeasurements
before and after the regular work shift for HR
exposed workers, but not among the non-exposed.
The resin investigated in this study used resorcinol
as the phenol donor and hexamethylenetetramine
(HMTA) as both a formaldehyde donor and a cata-
lyst. There was no association between lung func-
tion and ambient levels ofresorcinol, formaldehyde,
hydrogen cyanide or ammonia. Mean concentra-
tions offormaldehyde were 0.05, 0.02 and 0.04 ppm
forHR-exposed, HR-notexposed, andcontrolgroup,
respectively. Decrease in pulmonary function was
related to the quantity of respirable particulates
obtained from personal samples. Chemical analysis
of particulates, however, was not performed. It is
unlikely that formaldehyde by itself was responsi-
ble for the change in pulmonary function for two
reasons: (1) the exposure level of formaldehyde
was very low and (2) no association between its
level and decrease in pulmonary function was ob-
served.
Eight cases of occupational asthma (three smok-
ers and five nonsmokers) were reported among 28
members ofthe nursing staffat a hemodialysis unit
where formalin was used to sterilize the artificial
kidney machine (125). Recurrent episodes of pro-
ductive coughaccompanied bywheeze were aprom-
inent feature and, for five persons, attacks had
extended over the previous three years. Inhalation
provocation tests were performed on five subjects
with histories ofrecurrent attacks ofwheezing. In
two ofthese subjects the test resulted in asthmatic
attacks like those experienced at work. Peak expir-
atory flow rates fell approximately 50% and wheez-
ing began 2 and 3 hr after exposure to formalin and
lasted for 10 hr to 10 days. Three of the five
subjects had no respiratoryreaction to inhalation of
formaldehyde similar to that experienced in the
dialysis unit. Two of the five had no symptoms,
whileonedevelopedconjunctivitis. Thislatterpatient
developed redness, weeping and sensations ofgrit-
tiness of the eyes when heavily exposed to forma-
lin. In the absence ofsymptoms and exposure there
was no apparent reduction in lung function. The
authors suggest that although formalin may not
have been the etiologic agent in all cases, it may
have increased the susceptibility to other agents,
which could, perhaps, explain the high incidence of
bronchitis-like symptoms. In the absence of a com-
parison group, an alternative explanation of the
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asthmabeingattributabletochancealonestillexists.
However, the explanation is unlikely because ofthe
high proportion of the staff which developed the
symptoms and because of the positive responses
observed after the inhalation provocation test.
Formaldehyde-related asthmaanddermatitiswere
also reported by Kerfoot and Mooney (121). A
survey of six Detroit area funeral homes showed
that embalmers were generally exposed to formal-
dehyde at mean levels ranging from 0.25 to 1.39
ppm with a total range of 0.09-5.26 ppm. They
experienced acute toxic effects including eye and
nose burning, sneezing, coughing, and headaches.
Asthma or sinus problems were reported by 3 out
of 7 morticians. In addition, two workers experi-
enced dermatitis, with one case being so severe
that he discontinued working for a period of time
until he recovered. Although it was the professed
intention of the authors to correlate the formalde-
hyde concentrations in each funeral home with the
irritant effects on embalmers who worked at the
particular funeral home, no data were presented to
that end in this study. A dosage effect was implied
in the sentence, "The morticians who spent more
time embalming than in general funeral work, also
experienced more complaints ofirritations." It was
not clear who and how many people were in the
study. Embalming agents contain formaldehyde as
well as a variety of other chemicals, such as tissue
moisturizers, smooth muscle relaxants, bleaches,
an auxiliary antiseptic agent (phenol), dyes, buff-
ers, wetting agents, waterconditioners and/or anti-
coagulants, perfumes and odor suppressors, and
vehicles (methanol, ethanol, and glycerine). In light
of the possible mixed exposure to a variety of the
above chemicals during embalming and the lack of
an appropriate control group in the study, the
relationship of formaldehyde exposure among em-
balmers to development of asthma and dermatitis
remalns inconclusive.
Yefremov (127) studied 278 workers at two wood-
processing plants where urea-formaldehyde resins
were used extensively. They reported that the
incidence of chronic diseases affecting the upper
respiratory tract was higher in workers exposed to
formaldehyde than in a control group consisting of
200 individuals of corresponding ages. The preva-
lence was from 28.1 to 58.3% depending on work
areas, amongformaldehyde-exposed workers, com-
pared to 13% among the controls. The highest
prevalence of disease (58%) was observed in the
workers at the hot press shop, where the concen-
tration of formaldehyde was 2.5 times that in the
cold press shop. Disease occurrence was 33.9% at
the cold press shop. In all work areas the formalde-
hydeconcentrationswerereportedlybelowthemax-
Environmental Health Perspectivesimum permissible concentration (0.4 ppm). Assum-
ingtheage-matchedcontrolsrepresentanappropriate
comparison group (no mention was made ofmatch-
ing on sex and smoking history), this report sup-
ports the hypothesis that exposure to formaldehyde
may lead to chronic respiratory diseases.
Kratochvil (128) examined a total of 18 workers
of a mean age of 35 with an average formaldehyde
exposure of 7 years in a clothing production plant.
Formaldehyde exposure occurred during storage
and processing of fabric impregnated with urea-
formaldehyde and melamine-formaldehyde resins.
Catarrhal conjunctivitis was found in 72% of the
workers; 28% of the workers exhibited a catarrhal
inflammation ofthe upper respiratory tract, 22% of
the workers exhibited chronic bronchitis diagnosed
in accordance with the criteria ofthe World Health
Organization, and 11% ofthe workers showed skin
changes. Lung function tests showed that the vital
capacity and the differential forced vital capacity
exhibited normal values for all workers. The con-
centrations of formaldehyde in these work areas
were below the maximum allowable concentration
(0.4 ppm). In the absence ofan appropriate control
group, an etiologic role of formaldehyde in devel-
opment ofthe above conditionsisuncertain. In fact,
the 22% incidence of chronic bronchitis among the
workers corresponded to the incidence ofthis con-
dition reported for a normal population ofa similar
age group.
Shumilina (129) reported ahigh incidence ofmen-
strual and reproductive function disorders among
446 women workers (130 finishers and 316 inspec-
tors) exposed to urea-formaldehyde resins. Form-
aldehyde concentrations of 1.2 to 3.6 ppm were
often found in the finishers' work area ofthe fabric
trimshop, whilelevels from0.04 to0.56ppmoccurred
in the inspectors' work area. A group of 200 sales-
women not exposed to formaldehyde was used for
comparison. The reproductive disorders reported
to be more common among those exposed included
menstrual disorders, increased complication during
pregnancy, and higher percentage ofneonates with
low birth weights. The role offormaldehyde in the
development of these disorders is uncertain, how-
ever, because ofthe lack ofinformation on the work
environment and the socioeconomic status of the
study and control groups. In addition, many of
these disorders are known to be associated with
physical and mental stress, personal habits (alco-
hol, cigarettes, caffeine consumption), nutritional
status, and other factors related to the socioeco-
nomic status of women. Still, these findings are
intriguing and indicate a need for further studies in
this area.
Neshkov and Nosko (130) reported a high inci-
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dence of sexual dysfunction among male workers
employed in aplant producingglass fiberreinforced
plastic. These workers were exposed to vapors of
phenol, formaldehyde, aniline, epichlorohydrin, di-
phenylpropyl, styrene and a combination of glass
fiber and glass-reinforced plastic dust. The levels of
each ofthese chemicals were 1.5 times the respec-
tive maximum permissible level in 63% ofthe sam-
ples (maximum permissible level offormaldehyde is
believed to be 0.5 mg/m3 or 0.4 ppm). Among the
143 workers examined, 58 (40.5%) had psycho-
neurologicandsexualcomplaints. Sexualcomplaints
included a diminution of libido, premature ejacula-
tion, a weakening erection and decrease in the
satisfaction derived from an orgasm. Analysis of
the sexual complaints revealed a direct relationship
tothe duration ofemployment atthe plant. Testicu-
lar dysfunction amongthe workers was also report-
ed, including decreased volume and increased vis-
cosity of ejaculate and decreased number of sper-
matozoids. The authors concluded thatthese sexual
dysfunctions weretheresultsofcomplextoxiceffects
of chemicals on the cells ofthe cortex and those of
the subcortical brain stem structures, which partic-
ipate in the regulation of sexual function. It is
impossible to determine how much of the sexual
dysfunction might be attributable to formaldehyde
since appropriate control groups were not included
and these workers were exposed to a variety of
toxic chemicals in addition to formaldehyde. Of
particular interest are reports of epichlorohydrin-
induced sterility in animals (131, 132).
Ishchenko and Pushkina (133) compared morbid-
ity and sick leave among 662 workers engaged in
the manufacture of phenol-fornaldehyde resins to
that among 473 unexposed workers. Several dis-
ease conditions were more common in the formal-
dehyde exposed group than inthe controls, particu-
larly from diseases ofthe respiratory tract (1.8-fold
among males and 1.4-fold among females). Among
women, the frequency of urogenital problems was
2.3 times more common in the exposure group.
Days absent from work due to illness among those
exposedexceededcontrols 1.5-to 1.6-fold. Although
the authors state that the age distribution of the
exposed and comparison populations was similar,
no description of the methods used to determine
morbidity (examination, self-report, or medical
records) was provided. In addition, uncontrolled
social factors, as recognized by the authors, may
play arole. In light ofthese limitations, the greater
number of lost workdays due to sickness and the
increased evidence of respiratory and urogenital
diseases amongtheexposed workers, although sug-
gestive, does not provide definitive evidence con-
cerning the role of formaldehyde.
157In a mail survey of 20 funeral homes in Los
Angeles (134), 57 of80 embalmers responded. Nine
(16%) reported symptoms compatible with acute
bronchitis and 17 (30%) were considered to have
chronic bronchitis. The 31 asymptomatics, howev-
er, had worked longer than the bronchitics (18
years vs. 11 years). In the absence of a control
group, these findings are, at best, suggestive.
Engel and Calnan (135) reported an outbreak of
dermatitis in a car factory. A total of 50 cases of
dermatitis were observed inthreeyears (1962-1965)
among 150 employees who handled rubber weather
strips coated with phenol-formaldehyde resins. The
workerswhodeveloped dermatitishadbeenexposed
to the adhesives containing phenol-formaldehyde
resins for from one day to two years before the
onset of the eruption, with an average period of
contact of 17 weeks. The average duration of the
eruption was 12 weeks, however, in three cases it
persistedupto21/2years. Theeruptionwasgenerally
an erythematous vesicular rash of the fingers and
hands. Three materials were handled by these
employees: (1) the rubber weatherstrips, used for
some years; (2) adhesive A and B introduced 4
years before in 1962 and supplied by the same
manufacturers; (3) toluene, which was the solvent
used to activate the adhesive. The rubber weather-
strips alone were ruled out as a cause because they
came from various suppliers and had not changed in
composition for a long time. The toluene would not
be expected to cause sensitization within a short
period oftime. Amongthe 29 patch-tested dermati-
tis patients, four (14%) gave a weak reaction to
phenol alone, while 65% had a positive reaction to
the adhesive resins. It is, therefore, probable that
formaldehyde in the resins was a causal agent.
Outbreaks ofdermatitis in several industries using
formaldehyde resins were reported by Schwartz,
Peck and Dunn (136). In a factory where plywood
waslaminated, 600casesofdermatitiswerereported
amongabout800workers duringthefirst sixmonths
of operation. In a second reported outbreak, over
40 workers out ofa total of100, developed dermati-
tis in a factory making tool handles from laminated
glassfabricandphenol-formaldehyde resins. Although
no unexposed group was available for comparison,
the high proportion offormaldehyde exposed work-
ers developing dermatitis is quite impressive.
In a hemodialysis unit where formalin was used
as a sterilant, 6 to 13 staff members developed
dermatitis within 3 weeks (137). Four of the six
were positive in patch tests with 3% formalin. It
was not clear why only the hemodialysis unit was
affected, since other units also used formalin. The
author speculated it might be due to the use of a
detergent that lowered the resistance ofthe skin to
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formaldehyde vapors and to the high temperature
and concentration of formalin in the preparation
room. Lack of controls hampers the interpretation
of these data.
Cohort and Case-Control Studies
The panel was not aware ofany published cohort
ofcase-control studies designed to evaluate the role
of formaldehyde in the development of disease or
abnormal conditions. Many mortality studies have
beenreported ofworkers fromoccupations orindus-
tries wherein formaldehyde exposure may have
occurred. For example, Moss and Lee (138) have
reported elevated risks oforal and pharyngeal can-
cer among male textile workers. They reported
77% excess deaths due to these cancers compared
with the male population of Wales and England.
These textile workers may have been exposed to
formaldehyde, since formaldehyde has been widely
usedinthetextileindustryforproducingcreaseproof,
crushproof, and shrinkproof fabrics. No environ-
mental measurements of formaldehyde, however,
were made in this study. A recent NIOSH survey
showed concentrations offormaldehyde in the tex-
tile plants in the U.S. ranging from 0.1 to 1.4
ppm.
Brosset al. (139)reported asignificantlyincreased
risk of nasal cancer among brickmasons, textile
workers and shoemakers. Textile workers also had
significantly elevated risk of cancer ofthe pancreas
and stomach. No information on formaldehyde con-
centrations was reported.
Decoufle (140) hasreported significantly increased
risks of cancer of the buccal cavity, pharynx and
larynx among male leather workers. Bladder can-
cer and malignant lymphomas were also associated
withincreased risks amongmale and femaleemploy-
ees in the leather industry. The cancer risk for the
employees was calculated relative to the risk for
those who were in clerical positions. A variety of
chemicals including formaldehyde, azo dyes, chro-
mium compounds and tanning extracts have been
used in the production of leather goods. Some of
these chemicals are carcinogenic in animals. Indus-
trial hygiene surveys of a calf skin tannery in the
U.S. showed concentrations offormaldehyde in the
finishing department ranging from 1 to 8.6 ppm
(141).
Matanoski (142) reported an excess of primary
liver cancer and lung cancer among pathologists
compared to radiologists. However, oral and pha-
ryngeal cancers were lower in the pathology group.
Although exposure estimates were not available,
Environmental Health Perspectivespathologists are more likely than radiologists to be
exposed to formaldehyde.
Although the above investigations were not de-
signed to study health effects offormaldehyde, the
results suggestthepossibility offormaldehyde being
carcinogenic in humans. The lack of precise infor-
mation concerning the number of persons exposed
to formaldehyde and the level ofexposure, in addi-
tion to the problems of confounding exposures,
makes interpretation of these reports regarding
formaldehyde difficult.
Conclusions
In summary, a wide variety of acute and chronic
health effects from formaldehyde exposure have
been reported. They include eye, nose and throat
irritation, headache; shortness ofbreath; wheezing;
dermatitis; chronic cough; excess phlegm; chronic
airwayobstruction; asthma; bronchitis; rhinitis; pha-
ryngitis; menstrual and reproductive disorders; sex-
ual dysfunction; and possibly cancer. These studies
were primarily of a cross-sectional design, thus,
they do not allow a clear determination ofthe order
of events. In addition, many studies lacked appro-
priate controls and/orenvironmental measurement,
making it difficult to clearly evaluate the role of
formaldehyde. Independent reports of respiratory
system disorders and dermatitis among persons
from a variety ofwork settings supply evidence on
the consistency ofthe association, and indicate that
formaldehyde is a likely contributor to the origin of
these diseases. Only three studies (120, 125, 127)
allowed an estimate of the strength of association
betweenformaldehyde andrespiratorydisease. The
riskofchronicrespiratory symptomsamongexposed
groups ranged from about 1.5 to 4.5 times that
among nonexposed groups, with little evidence ofa
dose gradient. The studies of dermatitis among
workers exposed toformaldehyde, althoughreport-
ing a high prevalence, lacked comparison popula-
tions necessary to estimate the strength of the
association. Respiratoryandintegumentarysystems
are plausible response sites since workplace expo-
sure to formaldehyde is likely to occurbyinhalation
or dermal contact.
The report ofexcessive menstrual and reproduc-
tive problems among women exposed to formalde-
hyde is provocative and, despite the study limita-
tions, indicates the need for further research in this
area. No reports of studies specifically designed to
evaluatethecarcinogenicityofformaldehydeinhuman
populations were available, but several such stud-
ies are in progress.
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Review of Planned and On-Going
Epidemiological Studies
of Formaldehyde
Planned and on-going investigations related to
formaldehyde exposure include one study of a new
technique of measuring formaldehyde, three stud-
ies investigating complaints, four epidemiological
studies of morbidity (cross-sectional and prospec-
tive), and six mortality studies (cohort, proportion-
atemortality, andcase-control). Thequestions being
addressed and an evaluation ofeach group of stud-
ies follows.
Measurement Technique
The use ofsolid absorbent surfaces for collecting
personal samples of vapor and particulate formal-
dehyde is being examined. This method should be
more sensitive and efficientthanthepresentimpinger
method, thereby permitting more accurate assess-
ment of environmental exposures. An occupational
study (cross-sectional morbidity) is planned, but
details have not yet been provided.
Investigation of Complaints Relating
to Formaldehyde
The results from three states are beingcompiled.
In Connecticut, persons complaining ofhealth prob-
lemsduetourea-formaldehydeinsulationcompleted
a questionnaire concerning their symptoms and air
levelsofformaldehyde weremeasured intheirhomes.
Occupants 489/794 of262 residences presented com-
plaints, the most common symptoms being eye,
nose, and throat irritation, and headaches. Formal-
dehyde concentrations ranged from 0 to 10 ppm
(mean of 1.5 ppm). About half of the complaints
were associated with levels of 0.5 to 10 ppm.
F. Marshall of the New Jersey Department of
Health obtained medical histories, all available infor-
mation on insulation, and patterns ofhealth effects
from residents with recently installed urea-form-
aldehydefoaminsulationwhocomplained offormalde-
hyde odor, irritation, or increased pre-existing ill-
ness patterns. In 40/55 homes investigated, the
most common symptoms were tearing of the eyes,
sore throat, cough, and runny nose. Air samples
were collected in 22 homes. In 14 homes where
formaldehyde was detected, levels ranged from
0.01 to 0.78 ppm.
In New Hampshire, the Bureau of Occupational
Health (M. Hilgemeier) administered a standard
questionnaire to residents with complaints associ-
ated withformaldehyde exposure. Standard NIOSH
159techniques were used to collect formaldehyde sam-
ples. About 90% of the samples were below 0.5
ppm; 10/77 dwellings were mobile homes.
The above studies on formaldehyde complaints
are all similar and suffer the same deficiencies.
None ofthem can be used to estimate prevalence of
symptoms nor can they be used to establish dose-
response relations. These shortcomings include:
(1) the surveys are conducted only among those
whocomplain, andalthoughtheprevalenceofsymp-
toms should be high, it is abiased sample; (2) there
are no controls and no measurement of other irri-
tants that could cause health complaints. Thus,
these studies are only suggestive of possible prob-
lems and by themselves provide little evidence of
cause and effect relationships.
Morbidity
R. Levine of the Chemical Industry Institute of
Toxicology studied approximately 100 West Vir-
ginia morticians in a cross-sectional study of lung
function (spirometry) and respiratory symptoms.
Employment and smoking histories were also ob-
tained. Industrial hygiene measurements made in
the mortality study of Ontario embalmers along
with symptoms during embalming, number ofbod-
ies embalmed, subjective assessment ofseverity of
fumes, and length of employment will be used to
assist in the estimation of exposure in this study.
Spirometry will be compared to predicted values
from Knudson, and internal comparisons will be
related to exposure after age, height, and smoking
adjustments. Data from this study are being ana-
lyzed in terms of the prevalence of respiratory
symptoms (cough, phlegm, dyspnea) and the rela-
tion ofpercentage ofpredicted pulmonary function
to employment (formaldehyde exposure) after ad-
justment for confounding variables. There is no
assessment of skin effects. It is not clear if acute
symptoms related to exposure are to be evaluated.
Although there is a good rationale for studying this
occupationalgroup, aninabilitytodetectasignificant
response in this study could be due to low cumula-
tive exposure (probably less than 8hr/day). Length
of exposure (years worked or latency) should be
adequate. If we assume 50 persons each (smoking
groups combined) in ahigh and low exposure group
(the optimal situation) there is an 85% chance of
correctly rejecting the null hypothesis of no differ-
ence in FEV between exposure groups, ifthe true
difference is 0.5 liters and a level is 5%. If the
symptom rate is 20% in the low exposure group,
there is less than a 50% chance ofcorrectly reject-
ing the hypothesis of no difference if the true dif-
ference is 20% at the 5% level (two-tailed test). As
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in all cross-sectional studies, estimates ofexposure
are only a crude indicator of actual exposure. This
is, however, one of the few studies to attempt to
assess long term effects of formaldehyde on lung
function. Although embalming fluid contains 1-2%
formaldehyde, other pulmonary irritants are also
present (e.g., phenol) but these may be at low
enough concentrations to have a minimal effect. A
comparison group (e.g., funeral directors) would
have provided more confidence in the results and
more power in the analysis.
The remaining three morbidity studies are of
residents in homes with urea-formaldehyde (UF)
foaminsulation. In the first ofthese, M. Thun ofthe
NewJersey Department of Health identified about
400 homes that had been insulated with UF foam
and an equal number ofcontrol homes. Information
gathered by-telephone interview included type of
home and insulation, formaldehyde odor, health
symptoms and other medical data, demographic
data on the occupants, and the period prevalence of
asthmatic attacks, wheezing, chest pain, stinging
or burning skin, burning or tearing eyes. Except
forwheezing, the controls reported a higher preva-
lence of symptoms than did UF foam households.
There was no detectable difference in the overall
incidence ofnew symptoms during the year. There
was, however, an association of increased symp-
toms and formaldehyde odor; the incidence of new
symptoms following installation of the insulation
was 2.7 times higher than in the months preceding
the insulation. About 64% of the residents of the
UF foam homes reported no problems at all related
to the foam insulation. There is the possibility of
selective recall in the remaining 36% of the study
group because of the possible publicity relating to
mobile homes and the specific questions relating to
insulation. Despite this potential bias, there was
little overall difference between study and compar-
ison populations. There was, however, a dose-
response relation (dose was based on odor). Unfor-
tunately, therewerenoenvironmental measurements
to correlate with odor perception and symptoms,
and apparently no control of other potentially con-
founding irritants other than formaldehyde. The
added insulation may have also increased other
respiratory irritants that could have raised the
symptom rate. It is not clearhowthe formaldehyde
odor was described to the subjects. This study has
been completed recentlyand should be available for
review shortly. The summary given the Panel sug-
gests little difference between the insulated and
control homes except when odor occurred.
M. Woodbury and C. Zenz of the Wisconsin
Department of Health and Social Studies are pro-
posingto study 110 newmobile home owners. Expo-
Environmental Health Perspectivessure measurements are to be made twice monthly
for 9 months. It is difficult to evaluate this prospec-
tive study because of the lack of detail provided.
Some of the questions that need answering are:
What are the health parameters that will be deter-
mined and how often are they being monitored?
Are there formaldehyde controls for the mobile
homes? Ifso, how are they selected? Ifno controls
are planned, the study will have limited value. Are
other respiratory irritants being measured (e.g.,
NO2)? About 50% of the homes are newer homes
with higher formaldehyde levels than the older
homes which are serving as controls and have mea-
surable but low levels offormaldehyde. Assuming a
20% symptom rate and 180 people in each exposure
group (high and low formaldehyde), there is about
an 85% chance ofcorrectly rejecting the hypothesis
ofno differences in symptoms when the true differ-
ence is 15% at the 5% a level, and about a 99%
chance of correctly rejecting the hypothesis of no
difference in FEV1 when the true difference is 500
mL at the 50% a level (two-tailed test). The effects
oflong-term chronic exposure cannot be estimated
by this study. These investigators also performed a
retrospective pilot study of 65 mobile home resi-
dents. The data will be mainly useful in the plan-
ning and execution of the prospective study.
L. Williams ofthe Oregon Department ofDisease
Monitoring and Control is planning to study 300
mobile home residents who responded to a health
questionnaire. The volunteers werefromtworegions,
coastal and inland. The purpose of the study is to
ascertain the effect of humidity, temperature, and
wind ventilation on "health effects to potential form-
aldehyde exposure." Inasmuch as the participants
in the study are volunteers, however, it is not a
random sample. Apparently, environmental mea-
sures are planned, but it is not known what other
information on insulation, demography, other pul-
monary irritants, humidity, temperature, etc., will
be collected. Although the details are unknown,
this study design does not promise to add very
much to our knowledge. The power in this study is
similar to the study by Woodbury and Zenz when
the following assumptions are made: (1) the two
exposure groups to low and high formaldehyde are
of equal size ( - 150); (2) the prevalence of symp-
toms is about 30% in low exposure group.
Mortality
H. Weiss ofthe Wisconsin Department ofHealth
and Social Sciences conducted a case-control study
of infant mortality by type of residence and found
an increased risk for mobile home residents. Socio-
economic status is only one of many sources of
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potential bias in this study. The completed study
should be reviewed, but the short description avail-
able suggests that the data will provide little, if
any, useful information on the effect of formalde-
hyde.
D. Grauman of the National Cancer Institute
proposestoevaluatethemortalityexperience(using
standardized mortality ratios [SMR] of a cohort of
about 11,000 medical technologists. This group is
exposed to other chemicals in addition to formalde-
hyde (e.g., chloroform and benzidine). No environ-
mental data are available, so there cannot be agood
estimate ofexposure-response relationships. Apos-
itive association will not be conclusive because of
the mixed exposure. A negative association will not
be conclusive because ofthe lack ofexposure infor-
mation and the possibility of low exposures. The
control group is to be the U.S. population. If15% of
the cohort are dead (n = 1650 cases) and if20% of
the deaths in the control population were from
cancer, there would be better than a 95% chance of
correctly rejecting the hypothesis of no difference
between exposed and controls if the true differ-
ences were 5% atthe 5% a level. Assuming 1/4 ofall
cancers were lung cancer, there is about an 80%
chance of correctly rejecting the hypothesis of no
difference if the true differences were 5% at the
10% at level (two-tailed test).
There are three mortality studies of embalmers.
J. Walrath is conducting a proportionate mortality
ratio (PMR) analysis ofabout 1500 morticians from
New York. The purpose is to determine whether
there is an excess proportion of deaths due to
specific malignant neoplasms compared to the gen-
eral population. Besides havingthe problems inher-
ent in a PMR analysis where the population-at-risk
is not available there is little exposure data (length
of exposure is estimated on the basis of the year
first licensed). Assuming the rate of lung cancer is
5%, there is better than a 99% chance of correctly
rejecting the hypothesis of no difference in lung
cancer rates when the true difference is 5% at the
1% a level (two-tailed test). Walrath is also con-
ducting another PMR study on about 1200 embalm-
ers from California. This study is very similar to
the one in New York, except there will be more
information on length of exposure which can be
evaluated. There is, however, no direct estimate of
exposure or smoking history or other confounding
exposures. If20% of the deaths were from cancer,
there would be a better than 90% chance of cor-
rectly rejecting the hypothesis of no difference in
cancer rates between exposed and controls if the
true differences were 5% at the 10% a level (two-
tailed test). R. Levine of the Chemical Industry
Institute of Toxicology is also studying embalmers
161using an SMR retrospective mortality design. The
cohort is composed ofOntario's funeral service pro-
fessionals licensed during 1914-1967. Date ofbirth,
date offirstlicensure, type oflicense, years licensed,
and place of employment are available for each
person. Observed mortality rates will be compared
to Canadian national and provincial mortality data.
Mortality will also be analyzed as a function of
exposure (years worked?). A retrospective indus-
trial hygiene assessment will consist of inquiring
about changes in funeral practices with time, sur-
veying several selected funeral establishments. The
survey will include air sampling foragents ofpoten-
tial health concern (e.g., formaldehyde, phenol) and
examinationofpurchaserecordstodetermineamount
and kind ofchemicals used. Presumably these data
are to be used in evaluating dose-response relation-
ships. Assuming the study population comprises
180 deaths (15% ofthe estimated cohort) and a 20%
cancer rate there is about a 50% chance ofcorrectly
rejecting the hypothesis ofno difference ifthe true
difference is 10% at 5% ot level (or an 85% chance if
the true difference is 15% at the 5% ot level). As a
group, these three studies of embalmers should
provide a good estimate ofpotential risk from form-
aldehyde exposure.
A. Blair at NCI and the Formaldehyde Institute
are collaborating on a proposed cohort mortality
study to develop age, race, and sex-specific mortal-
ity rates among formaldehyde-exposed workers.
Rates will be compared with those in the U.S.
population and local or regional populations where
appropriate.
The first phase of the investigation is to deter-
mine ifthere is a suitable cohort for study. Suitabil-
ity will be based on representatives of the partici-
pating companies, range ofexposure, availability of
a cohort of at least 3,000 workers with a minimum
15-year latent period, suitable age distribution, and
sufficient information for adequate follow-up. Ifthe
requirements for a scientifically sound study are
met, the study will proceed. Formaldehyde expo-
sure for each individual will be estimated usingjob
titles, work locations, past environmental measure-
ments, years of employment, and the presence of
potentiallyconfoundingexposures. Theexposedgroup
will be stratified by intensity and duration ofexpo-
sure, age and year offirst exposure, susceptibility,
and latency.
The cohort should be large enough to engender
confidence in the differences in mortality experi-
ence ofstudy andcomparisonpopulations. Although
exposures are unlikely to be pure formaldehyde,
because of the varied occupational exposures and
size of the cohort, it may be possible to assess the
individual contribution of formaldehyde. Although
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the assessment of exposure is retrospective, it can
still be at least semiquantitative. This is a very
important part of this study and should employ a
full-timeindustrialhygienistfollowingmethodssim-
ilar to those of Emsden at the University of Pitts-
burgh. It is important that all companies partici-
pate in the study, as the results may be seriously
biased if some do not.
Conclusions
Ofallthemortality studiesproposed, those exam-
ining the medical technologists, embalmers, and
formaldehyde workers are the only ones that can
assess the carcinogenic risk among those individu-
als exposed. Although single epidemiologic studies
usually cannot adequately assess an occupational
risk, or the risk of exposure to a chemical agent,
taken together these studies should help clarify the
situation. There are, however, a number of con-
cerns about these studies.
* Are exposures to formaldehyde high enough in
these populations to assess possible effects?
For example, are embalmers exposed 8 hours/
day, 5 days/week, or is their exposure much
less?
* Can exposure history be adequately doc-
umented? Are individuals with little or no
embalming experience distinguishable from
those with considerable exposure? Since
few if any of the workers are exposed only
to formaldehyde, what is the effect of expo-
sure to these other agents?
* Is exposure to formaldehyde in the same range
as for other populations?
The confidence we place in the findings from
these studies depends largely on the ability to
retrospectively estimate exposure. If exposure in
these occupational groups isrepresentative ofother
exposed populations, the conclusions may be indica-
tive of potential risk to all exposed populations. If
these studies do not adequately address the above
questions, thenfurtherinvestigationmayberequired.
Suchinvestigation maybe pursued within the exist-
ing data set, or new populations may need to be
investigated.
Recommendations for
Epidemiologic Research
Thereisaneedforcarefullydesignedepidemiologic
studies to evaluate the role formaldehyde may play
in the origin of certain chronic diseases. Specific
research areas identified by the panel include the
following: (1) additional studies of chronic respira-
Environmental Health Perspectivestory system disorders that include environmental
measurements to allow a more precise estimate of
risk at various exposure levels, including industri-
al, as well as mobile home populations; (2) projects
designed to confirm or deny the association ofmen-
strual andreproductive disorders andformaldehyde
exposure reported by Shumilina (45); (3) more com-
plete epidemiologic studies to evaluate the carcino-
genicity of formaldehyde in human populations.
Although several projects are under way, there is a
need to bealertforresources foradditionalresearch.
The widespread use of formaldehyde in industry
and its occurrence in a variety of consumer prod-
ucts may provide opportunities for other studies.
The many uses offormaldehyde are summarized in
the NIOSH Criteria Document (108) and will not be
itemized here. It is sufficient to say that the chemi-
cal is of importance in adhesives for particle board
and plywood production; resins to mold a variety of
plastic parts for automobiles, appliances and hard-
ware; wrinkle-resistance in textile manufacturing;
strengthening of various paper products (grocery
bags, wax paper, napkins and tissues, and filter
paper); specimen preservation; mildew prevention;
insulation; and protective coatings.
It may be possible to identify other formalde-
hyde-exposed cohortsforstudy. Themajordifficulty
is that, for most occupations or industries, only a
small proportion ofthe workers have actual contact
with formaldehyde. This is clearly demonstrated
fromthe NIOSH Occupational Hazard Survey, Phase
I, 1972-1974, where 4,636 plants were studied in
over600differentindustrytypes(accordingtoS.I.C.
codes). These plants employed 895,725 workers in
453 different occupations. Products containing form-
aldehyde were encountered in 396 separate S.I.C.-
coded industries. Table 1 lists the percentage of
workers exposed to formaldehyde in the industries
with the larger work forces, and those ofparticular
interest.
This survey confirms an impression given by
published reports that exposure to formaldehyde is
more common in medical and laboratory environ-
ments and in certain parts ofthe textile, wood, and
paper industries. In certain industries, however,
the number ofwork places and workers studied was
small and the survey may not have included those
where significant exposure to formaldehyde occurs
(e.g., the chemical manufacturing industry).
The Industry-wide Studies Branch of NIOSH is
carrying out an industrial hygiene study offormal-
dehyde exposure in several industries in search ofa
suitable cohort for a mortality study of formalde-
hyde exposed workers. Measurements will be made
in industries concerned with formaldehyde manu-
facture, textile and clothing production, wood fur-
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Table 1. Percentage of workers exposed to formaldehyde.
% of workers
Industry exposed
Medical
Veterinarian and animal hospitals 23.0
Funeral services 100.0
Medical laboratories 31.0
Construction
Forestry services 10.5
General building contractors 3.6
Heavy construction 3.7
Plastering and lathing 5.4
Textiles
Finishing plants (synthetics) 11.6
Coated fabrics 14.0
Hats and caps 47.0
Fabricated textile products 3.3
Wood and paper
Veneer and plywood 21.0
Wood products 8.6
Upholstered furniture 12.2
Paper mills 5.8
Paper coating and glazes 9.0
Bags (except textiles) 11.1
Paints and allied products 16.9
Fabricated rubber products 29.0
Abrasive products 11.0
niture and wood and paper product manufacture.
Fifteen site visits are planned and these will be
completed over the next six months.
The major difficulty of the mortality studies of
individuals exposed to formaldehyde is the limited
ability ofsuch studies to detect excess risk for rare
causes ofdeath. Sincetheknowncarcinogenicaction
of formaldehyde is limited to the nasal sinuses in
rats, there is a need to evaluate the risk forthis site
in man, although it is clear that carcinogens may
not affect the same tissues in humans as in labora-
tory animals. It is unlikelythat a cohort ofsufficient
size can be assembled to accomplish this task; how-
ever, a carefully designed case-control studymight.
The panel suggests that the feasibility of perform-
ing a case-control study of cancer of the nasal
sinuses in areas where there is heavy production or
use offormaldehyde as a vapor should be explored.
Evaluation of Risk
Nasal Tumor Risk in Rats Due
to Formaldehyde Inhalation
Existing data on humans exposed to formalde-
hyde provide no quantitative estimates of the inci-
dence ofirreversible diseases. Epidemiologic stud-
ies areinprogress whichmaybeusefulinidentifying
163and estimating chronic disease risk due to formal-
dehyde vapor exposures.
A study was sponsored bythe Chemical Industry
Institute ofToxicologytoinvestigate thetoxiceffects
of inhalation of formaldehyde vapor in Fisher 344
rats and B6C3F1 mice. Animals were exposed to
average dosages of formaldehyde vapor of 0, 2.1,
5.6 and 14.1 ppm for 6 hr/day, 5 days/week, for 24
months. A total of 120 animals/species/sex were
exposed at each dosage level. Withineach group, 10
animals were sacrificed at 6 months, 10 animals at
12 months and 20 animals at 18 months. The fre-
quency ofnasal tumors in Fischer 344 rats through
the 18 month sacrifice wasreported by Swenberget
al. (79). Since no significant differences were noted
in the frequency of nasal tumors between sexes
during the first 18 months of exposure, the results
forthe sexes were combined. No nasal tumors were
observed prior to 12 months. The results given are
summarized in Tables 2 and 3.
Tumors in two categories were considered for
risk analysis: squamous cell carcinoma and total
nasal tumors. Since time-to-tumor data were not
presented by the authors risk analyses are per-
formed only on the unadjusted tumor rates of ani-
mals dying with tumors prior to 18 months. The
number ofunscheduled sacrifice animals at risk for
the combined sexes prior to 18 months is 200 per
dose.
Using a procedure given by Crump et al. (143),
the multistage model of carcinogenesis was fit to
the proportion ofanimals dying with tumors before
18 months. Note thatthis analysis does not give the
Table 2. Frequency ofnasal tumors in animals dying prior to
18 months.
Tumor frequency
Dosage, Number Squamous Squamous Spindle cell
ppm dying papilloma cell carcinoma sarcoma
0 2 0 0 0
2.1 2 0 0 0
5.6 8 0 0 0
14.1 44 4 28 1
Table 3. Frequency ofnasal tumors in animals sacrified at 18
months.
Tumor frequency
Dosage, Number Adenomatous Squamous cell
ppm examined polyp carcinoma
0 40 0 0
2.1 40 1 0
5.6 40 1 0
14.1 40 1 8
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probability of death due to tumors. Time-to-tumor
and cause ofdeath data are not given by Swenberg
et al. (79); hence a competing risk analysis utilizing
the sacrificed animals cannot be performed. The
upper 95% confidence limits for the proportion of
animalsdyingwith squamous cell carcinomasbefore
18 months were 0.3, 2.0 and 17.1% for 2.1, 5.6 and
14.1 ppm, respectively. Even though no squamous
cell carcinoma were observed at the two lower
dosages, because of statistical uncertainty there is
no guarantee that squamous cell carcinomas cannot
occur at 5.6 ppm or less in Fischer 344 rats within
18 months.
Since the true form of the dose response curve
below 2.1 ppm is unknown, nasal tumor rates in
rats exposed below this level cannot be predicted
directly. Since the dose response is curving upward
(convex), the potential nasal tumor rates at lower
dosages are predicted to be proportionately lower
than the potential risk at 2.1 ppm. The upper
confidence limit on the rate of squamous cell carci-
nomas is 0.3% at 2.1 ppm. At 1 ppm the risk is
predicted to be at least a factor of 2.1 lower, i.e.,
0.003/2.1 = 0.0014, etc. In general, proportional
dose response predictions (linear extrapolation) for
dosages below 2.1 ppm are given by: Squamous cell
carcinoma rate
- 0.0014 x dosage (ppm).
Similarly, the upper 95% confidence limit for the
proportion of animals dying before 18 months with
a:
a)
c co
0 5 10
Formaldehyde Dosage (ppm)
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FIGURE 4. Potential proportion ofFischer344 rats dyingwith
squamous cell nasal carcinomas before 18 months.
Environmental Health Perspectivesany nasal tumor is 0.33%, giving: Total nasal tumor
rate
- 0.0016 x dosage (ppm). For example, the
proportion of animals dying before 18 months with
squamous cell carcinomas in Fischer 344 rats is
predicted to be no more than 1.4 per 1000 animals
at an exposure of 1 ppm formaldehyde for 6 hr/day,
5 days/week. The low dose extrapolation procedure
is illustrated in Figure 4.
The rat data indicates a potentially high nasal
tumor rate at inhalation exposure levels compara-
ble to levels which can be experienced in homes and
occupational environments. Perhaps the epidemiol-
ogy studies in progress will provide direct tumor
risk information for humans exposed to formalde-
hyde.
Conclusions
The metabolic pathways for formaldehyde in var-
ious animals species and man are qualitatively the
same but differ in rate with formaldehyde or a
formaldehyde adduct likely to be the carcinogenic
agent.
Most of the studies available on the possible
teratogenicity or reproductive effects of formalde-
hyde are inadequate for evaluation and none are
adequate for exposure by inhalation.
Formaldehyde is mutagenic in a variety of test
systems, including bacteria, yeasts, fungi, insects
and mammalian cells and causes mutations and
chromosome aberrations.
By inhalation formaldehyde is carcinogenic to the
Fischer 344 rat, producing nasal tumors at dose
levels that are within the same order ofmagnitude
as those to which humans are exposed.
Formaldehyde may be carcinogenic to species
other than the rat and to tissues other than nasal.
Formaldehyde should be presumed to pose a
carcinogenic risk to humans.
No information is presently available whether
(a) certain individuals may be at greater risk of
cancer from formaldehyde exposure, (b) tumors
may be expected to arise at nonrespiratory sites as
a result of inhalation of formaldehyde by humans,
or (c) the effects of formaldehyde exposure may
contribute in an additive or synergistic way to the
effects of other carcinogens or tumor promoters.
We thank Ms. Eva S. Lehman, CPSC, for her assistance in
the preparation ofthe manuscript.
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